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ABSTRACT 
The structure of RNA molecules is crucial to regulating gene expression1, largely 
through influencing interactions with RNA binding proteins (RBPs). Hybridization 
individual-nucleotide resolution UV crosslinking and immunoprecipitation (hiCLIP) 
is a transcriptome-wide method to monitor these interactions by identifying RNA 
duplexes bound by a specific RBP. The hiCLIP protocol consists of the following 
steps: in vivo crosslinking of RBPs to their bound RNAs; partial RNA digestion and 
purification of RNA duplexes interacting with the specific RBP using 
immunoprecipitation; ligation of the two arms of RNA duplexes via a linker; reverse 
transcription; cDNA library amplification, and finally high-throughput DNA 
sequencing. Mapping of the sequenced arms to a reference transcriptome identifies 
the exact locations of duplexes. hiCLIP data can directly identify all types of RNA 
duplexes bound by RBPs, including those that are challenging to predict 
computationally, such as inter-molecular and long-range intra-molecular duplexes. 
Moreover, the use of an additional adaptor that links the two arms of the RNA duplex 
permits hiCLIP to unambiguously identify the duplexes. Here we describe in detail 
the procedure for a hiCLIP experiment and the subsequent streamlined data analysis 
with an R package, “hiclipr” (https://github.com/luslab/hiclipr). Preparation of the 
library for high-throughput DNA sequencing takes approximately seven days, and the 
basic bioinformatic pipeline takes one day.  
 
INTRODUCTION 
RNA structures play a pivotal role in the regulation of gene expression. Appropriate 
folding of RNA is essential for the assembly of ribonucleoprotein (RNP) complexes, 
such as the ribosome and spliceosome, and their catalytic activities. Moreover, RNA 
structure also modulates the binding of regulatory molecules to mRNAs, such as 
micro RNAs (miRNAs) and RNA binding proteins (RBPs) that control production of 
encoded proteins1,2. One of the central aspects of RNA folding is the formation of 
RNA duplexes. Intra-molecular RNA duplexes result from base pairing within an 
RNA molecule, which can lead to diverse RNA structural motifs, such as the stem-
loop and pseudoknot3. In addition, inter-molecular RNA duplexes can arise from base 
pairing between different RNA molecules, including miRNA-mRNA4, lncRNA-
mRNA5,6, and mRNA-mRNA duplexes7, among others8-11. Due to their importance, 
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various methods have been developed to assess comprehensively the nature and role 
of RNA structures and duplexes in a cell with high-throughput DNA sequencing.  
 
High-throughput DNA sequencing approaches to study in vivo RNA structures 
Two primary approaches use high-throughput DNA sequencing to study RNA 
structures: (i) methods that employ nucleotide probing, using chemicals with different 
reactivity for single-stranded or double-stranded nucleotides, and (ii) methods that 
employ proximity ligation to join the two strands of RNA duplexes2 (Fig. 1).  
 
The first genome-wide method to study RNA structures, named parallel analysis of 
RNA structure (PARS), probes single- or double-stranded nucleotides using RNases 
that preferentially cut either single-stranded or double-stranded regions, and analyzes 
the probed sites using high-throughput DNA sequencing12. However, this RNase-
based approach can only be used in vitro with purified RNA. In order to study in vivo 
RNA structures, methods using cell-membrane-permeable chemicals to probe single-
stranded nucleotides in vivo were developed. These methods, including dimethyl 
sulphate-sequencing (DMS-Seq)13,14 and in vivo click selective 2'-hydroxyl acylation 
and profiling experiment (icSHAPE)15,16, revealed the general characteristics of RNA 
structures in the cell. However, the data need to be interpreted with caution to gain 
insights into these structures, since the in vivo nucleotide probing efficiency can be 
influenced not only by single-strandedness, but also by associated proteins, which can 
confound the analysis17. In addition to assessing the single-strandedness of 
nucleotides, the information can also be used to improve the accuracy of 
computational predictions of RNA secondary, or potentially even higher-order, 
structures13-15,18. However, these methods share some of the same limitations as the 
current computational RNA structure prediction tools. They have difficulties 
resolving long-range intra-molecular RNA-RNA contacts or inter-molecular RNA-
RNA contacts, where too many possible alternative structures need to be considered. 
Furthermore, the prediction of tertiary RNA structures such as pseudoknots and 
kissing-loops remains challenging for most programs19.  
 
An alternative approach to studying RNA structures uses proximity ligation, which 
directly identifies RNA duplexes. Here, single-stranded RNA is digested, leaving 
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behind the RNA duplexes; the two duplex arms are then ligated to generate a single 
hybrid RNA molecule. Thus, by analyzing the hybrid RNAs using high-throughput 
DNA sequencing, it is possible to examine which regions of RNAs form duplexes. 
The first high-throughput method using proximity ligation, termed crosslinking, 
ligation, and sequencing of hybrids (CLASH), was developed to study in vivo RNA 
duplexes recognized by a specific RNA binding protein20. CLASH uses a modified 
version of the CLIP protocol. Like CLIP, CLASH employs UV-C irradiation to 
crosslink RBPs to the bound RNAs, followed by immunopurification of the RBP-
RNA complex. These RNA fragments are then identified using high-throughput DNA 
sequencing. In CLASH, there is an additional proximity ligation step, which is 
designed to ligate together the two arms of the isolated RNA duplexes. CLASH has 
been successfully used to study RNA duplexes formed by snoRNA-rRNA20 and 
mRNA-miRNA21,22 in a genome-wide manner.  
 
While CLASH can identify in vivo RNA duplexes recognized by RBPs in a high-
throughput manner, it does not examine the structures of unbound RNAs. In order to 
study all RNA duplexes in the cell, methods crosslinking the two arms of RNA 
duplexes using a psoralen derivative (4’-aminomethyltrioxalen: AMT) were 
developed. The psoralen derivative, AMT, is a water-soluble chemical that can form 
crosslinks between double-stranded uridine and its opposing nucleotide upon 
irradiation with 365 nm UV light; the crosslinks can be reversed by irradiation with 
254 nm UV light23,24. The psoralen-crosslinking based methods include sequencing of 
psoralen cross-linked, ligated, and selected hybrids (SPLASH)9, psoralen analysis of 
RNA interactions and structures (PARIS)10, and ligation of interacting RNA followed 
by high-throughput sequencing (LIGR-Seq)11. These methods first crosslink RNA 
duplexes by incubating the cells with psoralen, purify the crosslinked RNA duplexes, 
ligate the two arms of RNA duplexes to generate hybrid RNAs, and analyze the 
hybrid RNAs in a similar way to CLASH. These psoralen-crosslinking based methods 
have been used to reveal a global view of RNA duplexes9-11. 
 
Development of hiCLIP 
We built on the insights of the CLASH technique in developing hiCLIP8, which also 
relies on proximity ligation to identify RNA duplexes bound by RBPs. hiCLIP 
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introduces a unique ligation step, where an additional linker is used to ligate the two 
arms of an RNA duplex (Fig. 1). Thereby, hiCLIP overcomes the following three 
limitations of other proximity ligation methods. First, a flexible single-stranded RNA 
next to the RNA duplexes is likely to be required to ligate the two arms of RNA 
duplexes, as was shown by the need of at least 8 nucleotides in an RNA for the 
efficient circularization8,25. Such single-stranded RNA overhang may not exist after 
the partial RNA digestion. The hiCLIP linker adaptor adds a flexible end to one arm 
of RNA duplexes, and thus enables the efficient ligation of the two arms. Second, 
potential endogenous ligase activity can make data interpretation more difficult24. Use 
of the linker ensures all hybrid reads arise as a result of the controlled ligation 
reaction. Third, separating the two arms of hybrid RNAs generated by the direct 
ligation is computationally challenging after sequencing. Introduction of the 
identifiable linker between the two duplex arms allows unambiguous identification of 
these two arms in hybrid reads before mapping. This enables hiCLIP to be applied to 
a variety of dsRBPs without the need for any prior information regarding the target 
RNA duplexes.  
 
 
Overview of the hiCLIP procedure 
Here we provide a detailed protocol for hiCLIP and subsequent bioinformatic analysis 
using a specific RBP and cell line as an example (FLAG-tagged Staufen 1 protein, 
STAU1,  in an HEK293 cell line). However, like CLIP26 or iCLIP27, hiCLIP should be 
generally applicable to any dsRBP, cell line or tissue with a few modifications 
considering the factors detailed in Experimental Design. 
 
The procedure to generate a high-throughput DNA sequencing compatible library 
consists of 10 stages (Fig. 2). (Stage 1) The cells are irradiated with UV-C light to 
form covalent bonds between directly interacting RBPs and RNA. The UV cross-
linking is used to stabilize the RNA duplexes on RBPs. This enables extensive 
purification of the RBP of interest in order to examine only those RNA duplexes in 
direct contact with the protein. (Stage 2) The cells are then lysed with a detergent-
containing buffer, and (Stage 3) RNA is partially digested using RNase I. (Stage 4) 
The RBP of interest and the crosslinked RNA duplexes are purified with 
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immunoprecipitation, and (Stage 5) a different type of RNA adaptor is ligated to the 3’ 
end of each arm of the RNA duplex. RNA Adaptor A has an irreversible 3’ block 
(dideoxynucleotide) that prevents additional molecules ligating to it, and later serves 
as a priming site of the reverse transcription primer. RNA Adaptor B has an 
enzymatically removable 3’ block (phosphorylation), and later serves as a linker when 
generating hybrid RNAs. With identical concentrations of Adaptors A and B, half of 
the RNA duplexes where both arms are ligated by adaptors will have one arm ligated 
by Adaptor A and the other arm ligated by Adaptor B. RNA duplexes ligated by only 
Adaptor A will be cloned as a non-hybrid RNA whereas RNA duplexes ligated by 
only Adaptor B will not be cloned. (Stage 6) The 3’ block of adaptor B is removed, 
and (Stage 7) the two arms of the RNA duplexes are ligated via adaptor B. Since the 
two arms of RNA duplexes are proximal to each other, they are the preferred 
substrates for the ligation reaction. (Stage 8) The RBP-RNA duplex complex is 
further purified with a second round of immunoprecipitation, SDS-PAGE, and 
nitrocellulose membrane transfer. To monitor the quality of experiments, a fraction of 
the RNA is radio-labeled before SDS-PAGE and visualized on nitrocellulose 
membrane using autoradiography. (Stage 9) The RNA is then extracted from the 
crosslinked RBP, (Stage 10) reverse transcribed with a primer containing a unique 
molecular identifier and the cDNA is PCR amplified to generate a library compatible 
with high-throughput sequencing, using a protocol similar to iCLIP27,28. 
 
The bioinformatic analysis (Stage 11) uses the tailored R package “hiclipr” 
(https://github.com/luslab/hiclipr).  First, hybrid reads are identified based on the 
presence of the linker sequence (Adaptor B), and defining the sequence of each 
hybrid arm. Each hybrid arm is mapped individually to a reference genome and 
transcriptome in four phases: (i) first, reads are aligned to annotated ribosomal and 
transfer RNAs; (ii) any  remaining unaligned reads are then mapped to the 
mitochondrial genome; (iii) next, remaining reads are aligned to a reference 
transcriptome and (iv) finally, remaining reads are mapped to the reference genome. 
Alignments from phase 1, 3 and 4 are combined for further analysis. Alignments from 
phase 2 are usually a tiny proportion of all alignments and are discarded as here we 
focus on cytoplasmic RNAs. In phases 3 and 4, only uniquely aligning reads are 
allowed and this alignment strategy maximizes the yield of aligned hybrid reads. PCR 
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duplicates are removed using a unique molecular identifier introduced by the reverse 
transcription primer. Each hybrid arm is then annotated with the gene of origin, the 
transcript biotype (e.g. protein-coding, microRNA, long-non-coding RNA) and the 
transcript region (e.g. 5’ UTR, CDS, 3’ UTR).  
 
To define RNA duplexes bound by RBPs, the intragenic hybrids (i.e. hybrids in which 
both arms align to the same RNA transcript) are further evaluated. If hybrid reads 
overlap, they are collapsed to a single representative read. Then, the two arms of all 
reads are computationally annealed to each other to predict the longest RNA duplex 
contained within. In addition, to estimate the occurrence of RNA duplexes bound by 
the RBPs, the number of hybrid reads overlapping with each duplex is used to score 
each duplex. 
 
The pipeline creates a number of plots that describe characteristics of the RBP-bound 
RNA duplexes including: (i) the transcript regions to which the arms align; (ii) the 
ratio of intragenic to intergenic hybrids (for those that occur in mature transcripts, 
rather than rRNA or tRNA); (iii) the loop lengths within 3’ UTR and CDS regions of 
intragenic duplexes (Fig. 3). It also calculates the genomic location of the duplexes, 
which can be exported to view in a genome browser (Fig. 4). All of these results are 
contained in the final table created by the pipeline, which can be analyzed further by 
the user using scripts tailored to their biological question of interest.  
 
Applications and advantages of hiCLIP 
hiCLIP is particularly useful for investigating the specificity of RBPs for different 
types of RNA structures, which is crucial to understand their roles in post-
transcriptional regulation. hiCLIP can examine multiple aspects of RNA duplexes: 
their preferred locations within different regions of RNAs; their sequence and 
structural characteristics; their  formation into intra- versus inter-molecular structures; 
and the distance between the two arms of the intra-molecular RNA duplexes8. Hybrid 
reads can also be used to study alternative RNA structural conformations in the cell, 
and how this may contribute to the regulation of RBP-binding2,8. 
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hiCLIP complements methods based on psoralen-crosslinking: hiCLIP focuses on 
determining RNA duplexes that are bound by specific RBPs, while the psoralen-
crosslinking based methods allow identification of RNA duplexes globally (Fig. 1). 
One potential advantage of hiCLIP over psoralen-crosslinking based methods is the 
shorter crosslinking time. UV-C crosslinking used in hiCLIP takes less than a minute, 
whereas psoralen crosslinking (including pre-incubation) requires 40-60 min in 
PARIS10 and LIGR-Seq11. In SPLASH9, psoralen crosslinking requires only 25 min, 
but here the pre-incubation includes a detergent that can affect cellular functions. 
Thus, hiCLIP may be more suitable to studying dynamic changes of RNA structure 
occurring over short time frames and with minimal perturbation of cells. 
 
Limitations of hiCLIP 
Similar to CLIP and CLASH (reviewed recently22,28), the requirement for 
immunoprecipitation limits the use of hiCLIP to endogenous RBPs for which high-
quality antibodies are available. While it is also possible to express tagged proteins or 
add a tag to the endogenous protein using genome editing techniques29, care must be 
taken to ensure that the added tag does not interfere with the functions of the RBP.  
 
While these high-throughput methods have provided general insights into the 
characteristics of RNA structures, many challenges remain. The required high 
complexity of cDNA libraries and sequencing depth may restrict in-depth analysis of 
full RNA structures to the most highly expressed miRNAs, mRNAs and other non-
coding RNAs, such as rRNAs, snRNAs and snoRNAs.  In the case of hiCLIP, the 
relatively long procedure includes potentially inefficient steps, including UV-cross-
linking and the generation of hybrid RNAs. The efficiency of UV-cross-linking varies 
depending on the RBP, but is estimated to be approximately 1-5% for most RBPs30, 
while the proportion of hybrid reads in the total sequence reads are 1-2%8. Therefore 
a large amount of starting material is currently required. This could be improved by 
incorporating knowledge obtained from recent efforts to optimize the iCLIP 
procedure31,32.  
 
Since the high-throughput methods to study RNA structures are relatively new they 
have only been applied in limited biological contexts. CLASH and similar methods 
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have been applied to yeast spliceosome related proteins (Nop1, Nop56, Nop58, and 
Brr2)20 and Ago2 proteins21,33,34, while hiCLIP has been applied to the human STAU1 
protein8. The psoralen-crosslinking based methods were only reported recently and 
were used to examine general characteristics of RNA structures. Comparative 
analyses between these studies may yield further insights into the characteristics of 
RNA structures and specificity of dsRBPs. Applying hiCLIP or other high-throughput 
methods to a wide variety of RBPs in various biological conditions will provide more 
comprehensive insights into the specificity of particular RBPs for different types of 
RNA structure.  
 
Experimental design 
Adaptor preparation. The use of two adaptors (Adaptor A and Adaptor B) is a key 
aspect of the hiCLIP protocol. For the generation of hybrid RNAs, Adaptor B, which 
is specially designed for hiCLIP, must be made from RNA as the enzyme used in this 
protocol (T4 RNA ligase) does not efficiently ligate RNA to DNA. The sequence of 
Adaptor A is identical that used in iCLIP. It is also RNA in order to achieve a similar 
ligation efficiency to Adaptor B. Of note, the adaptors described here can be used for 
the study of any RBPs and materials from both cultured cells and tissue without any 
modifications. 
 
In vivo UV crosslinking. hiCLIP uses UV-C irradiation of the cell to crosslink RNA 
duplexes directly bound by RBPs. This covalent crosslinking allows later stringent 
purification to eliminate any associated RBPs and RNA that have not been 
crosslinked to the RBPs. Depending on the types of materials (e.g. cultured cells or 
tissues) or analyzed RBPs, the crosslinking step may require optimization to 
maximize the crosslinking efficiency. Generally, a relatively short exposure of UV-C 
light (from 100 mJ/cm2 to 150 mJ/cm2) is used for cultured cells8,27,35, while longer 
and repeated exposure (e.g. 4 times at 100 mJ/cm2 or successive irradiation at 400 
mJ/cm2 and 200 mJ/cm2) is used for tissues28,36. Past studies have shown that pre-
incubating cells with photo-activatable nucleosides to incorporate them into RNAs, 
followed by UV-A irradiation can improve the crosslinking efficiency for certain 
RBPs37, compared to the standard UV-C crosslinking described here.  
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Choice of cell lysis buffer. The crosslinked protein-RNA complexes are extracted 
from the cell by lysing the cell with detergent-containing buffer. The cell lysis buffer 
should be chosen according to the cell fractions to be extracted, the stability of RNA 
duplexes, and the immunoprecipitation efficiency (see also the Immunoprecipitation 
section below). The use of different detergents allows the purification of RBPs and 
crosslinked RNA complexes in the different cell fractions38-40 (manufactures of 
antibodies such as abcam offers a useful guide to chose appropriate detergents in their 
website; e.g. http://www.abcam.com/ps/pdf/protocols/WB-beginner.pdf). In the 
Procedure, cells are lysed with buffer containing 1% (vol/vol) of non-ionic detergent, 
Triton-X 100, without mechanical disruption. This relatively mild treatment does not 
completely disrupt nuclei, allowing collection of the cytoplasmic lysate to study the 
RNA duplexes present in the cytoplasm. A more stringent buffer containing ionic 
detergents combined with mechanical disruption would be required to lyse the nuclei 
completely to study RNA duplexes from whole cells.  
 
The buffer should not disrupt RNA duplexes before the ligation of the two arms. We 
therefore avoid the use of EDTA or denaturing reagents in the buffer at the cell lysis 
stage. Nevertheless, CLASH identified snoRNA-rRNA and miRNA-mRNA duplexes 
in spite of using a buffer containing 6M guanidine hydrochloride before the 
hybridization of the duplexes20,21, which is known to denature proteins due to its 
chaotropic properties. It remains to be seen if duplexes are fully resistant to the 6M 
guanidine hydrochloride, or if the duplexes were resistant because they were ligated 
by the endogenous ligase before this step33. 
 
Partial RNA digestion. For proximity ligation, RNAs surrounding the duplexes need 
to be digested by the use of RNase or other methods. An appropriate level of RNA 
digestion is crucial for the success of hiCLIP experiments. The RNA length should be 
short enough that the sequence can identify the exact region of the duplex recognized 
by RBPs, and the full length of hybrid reads can be sequenced, but long enough that 
the RNA source can be uniquely identified. The experimental conditions are 
optimised with the aim to produce hybrid reads with arm lengths between 16 nts and 
40 nts. 
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We use RNase I since it can cleave RNA at all four bases, and preferentially digests 
single-stranded RNA, thus leaving RNA duplexes intact. To identify the optimal 
digestion conditions, we test serial concentrations of RNase I (typically a range from 
0.5 U ml-1 to 20 U ml-1) and monitor the degree of digestion by autoradiography after 
nitrocellulose membrane transfer. In ideal digestion conditions, a diffuse signal of 
RNA-protein complexes should be visible above the molecular weight of the RBP of 
interest35 (see Fig. 5).   
 
Immunoprecipitation. Both the efficiency and specificity of immunoprecipitation 
are important for hiCLIP. The efficiency can be monitored using western blotting by 
comparing the signal of the input and immunoprecipitated fractions. The absence of 
other RBP or non-crosslinked RNA contaminations can be monitored by 
autoradiography (see Control experiments and Fig. 5). Optimization may be required 
for successful immunoprecipitation; relevant considerations have been discussed 
previously28. Since dsRBPs often do not have a high crosslinking efficiency, it is 
crucial for hiCLIP that all RBPs associating with the target RBP are removed. In the 
case of many RBPs, these associating RBPs are eliminated with the “harsh” 
immunoprecipitation condition of the standard iCLIP (e.g. washing with the buffer 
containing an ionic detergent such as SDS and high salt). However, in the case of 
some RBPs such as STAU1, two rounds of immunoprecipitation are required to 
eliminate the associated RBPs completely35. This includes the first standard round of 
immunoprecipitation, extraction of the RBP of interest from the beads by protein 
denaturation, followed by a second round of immunoprecipitation. 
 
When employing two rounds of immunoprecipitation, the antibody used for the first 
round of immunoprecipitation is covalently coupled to Dynabeads Epoxy beads (used 
in the Dynabeads antibody coupling kit). This obviates contamination of the second 
round of immunoprecipitation by denatured antibodies from the first round. For the 
second round of immunoprecipitation, we attach the antibody to Dynabeads Protein G, 
because our initial optimization experiments indicated that they have less non-specific 
binding of protein and/or RNA than Dynabeads Epoxy beads (data not shown, YS). 
 
   
12 of 56 
SDS-PAGE and nitrocellulose membrane transfer. It is essential to purify only 
crosslinked RNAs. Short non-crosslinked RNAs and the free radioactive ATP used 
for RNA labeling are removed during the SDS-PAGE, since they migrate close to the 
front of the gel that is removed before the transfer. The remaining non-crosslinked 
RNAs are removed during the nitrocellulose membrane transfer, since nitrocellulose 
membrane binds to proteins but not nucleic acids41. A large amount of radioactivity is 
lost after nitrocellulose membrane transfer, indicating that this step is essential to 
eliminate non-crosslinked RNAs. 
 
In the Procedure, we use radio-labelling of RNA for isotopic detection of protein-
RNA complexes on the nitrocellulose membrane.  Alternatively, protein-RNA 
complexes can be visualized by ligating a infrared-dye-conjugated adaptor, as has 
been recently developed for irCLIP32.  Radiolabeling is highly sensitive and has a high 
signal-to-noise ratio, but experiments handling radioactive materials have to be done 
in a controlled environment with due care. So, if a sufficient amount of protein-RNA 
complexes is purified, non-isotopic labeling is less onerous.    
 
Reverse transcription and multiplexing of libraries. The reverse transcription 
primer adds a unique molecular identifier and an experimental barcode sequence to 
the cDNA. The hiCLIP data analysis pipeline analyzes the unique molecular 
identifiers to distinguish PCR duplicates from unique cDNAs that have the same 
sequence, and thus refines the quantification in each experiment. This analysis is also 
useful to evaluate the depth of high-throughput DNA sequencing. If most cDNAs 
have been sequenced only once, it indicates that the library has a high cDNA 
complexity, and could be re-sequenced for greater sequence depth. 
 
To reduce the cost of sequencing, the experimental barcode allows multiplexing 
several libraries and sequencing them in the same lane, since the samples can be 
deconvoluted from the sequence reads using this barcode. In the original hiCLIP 
paper, we multiplexed three libraries at this step8. Should the sequencing results 
indicate an inadequate depth of sequencing, the library can later be re-sequenced. 
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When multiplexing libraries, we designed each experimental barcode sequence in the 
reverse transcription primer to differ at least by two nucleotides so that each barcode 
could still be unambiguously identified despite sequencing errors. Another 
consideration is the timing of multiplexing. In principle, the libraries can be 
multiplexed immediately after reverse transcription since the experimental barcode 
has already been introduced into the cDNAs. However, at this step, precise 
quantification of the libraries is difficult. In light of this, we multiplex the libraries 
after PCR amplification and quantification of each library.  
 
Library quantification. Libraries for high-throughput DNA sequencing can be 
quantified by qPCR (SYBR Green based / TaqMan based method), fluorescence 
measurement using fluorophores binding to DNA (e.g. Quant-it DNA assay kit by 
Thermo Fisher Scientific), or Agilent Bioanalyzer / Agilent TapeStation28.  We 
recommend the TaqMan based qPCR method for hiCLIP library quantification, as it 
allows highly sensitive and precise quantification of the molar concentration 
regardless of the DNA length distribution in the library. 
 
DNA sequencing. In general, sequencing of hiCLIP libraries requires longer 
sequence reads than CLIP and iCLIP, as it is important to sequence the full hybrid 
containing both duplex arms. The length of hybrid reads depends on the length of the 
original RNA fragments, which is determined by the degree of RNase digestion. We 
initially sequenced 196 nt long reads using MiSeq Gene & Small Genome Sequencer, 
but longer sequence reads could be produced without any problems. 
 
Control experiments. Appropriate control experiments are necessary to monitor the 
quality of the hiCLIP experiment. To monitor the protein-RNA complex purification 
specificity, we recommend control samples that omit UV-C crosslinking and samples 
that lack expression of the target RBP (e.g. knockout or knockdown for endogenous 
RBPs, or omitting induction in the case of inducible expression). These controls are 
especially important for the preliminary experiments to optimize the purification 
conditions. For the full hiCLIP experiment, an additional control omitting the second 
round of ligation can be used to confirm that hybrid reads require both rounds of 
ligation. 
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Preliminary experiments. Before applying hiCLIP to new RBPs, we generally 
perform preliminary experiments to optimize the UV crosslinking, lysis buffer, RNase 
digestion, and immunoprecipitation steps by considering the factors listed above. In 
these experiments, we perform the hiCLIP procedure up to and including the 
autoradiograph steps, but skip the adaptor ligation and inter-molecular ligation steps 
(Steps 23 – 48 and 57 – 73). The autoradiograph is used to evaluate each condition 
(Fig. 5). 
 
Bioinformatic analysis. The hiCLIP data analysis R package “hiclipr” presented here 
is a more user-friendly version of the pipeline described before8. It is set up to analyze 
data from human samples. We have updated the annotations used to Ensembl 
GRCh37, release 75, which is currently the static archived GRCh37 release. The 
internal datasets would need to be modified for other species or assemblies. We have 
also expanded the hybrid read selection method. Only hybrid reads separated by a 
single linker were considered in the original study. However, we found that a small 
proportion of reads contain runs of more than one interrupting linkers (~8% of all 
reads containing at least one linker) presumably due to the incomplete 3’ blocking of 
the linker adaptor. These are now included as hybrid reads in the new package.  
 
In the Procedure, we describe the basic analysis to detect and annotate RBP-bound 
RNA duplexes. More advanced analyses would require further scripts tailored to the 
biological questions of interest. 
 
MATERIALS 
REAGENTS 
• Appropriate cell line or tissue. In the Procedure, we use FLAG-STAU1-Flp-In 
293 T-REx cells: The cell line is produced from Flp-In 293 T-REx cells 
(Thermo Fisher Scientific, cat. no. R780-07) by transfecting pcDNA5/FRT/TO 
plasmid with FLAG-STAU1 (GenBank accession number of the STAU1 
coding sequence: NM_017454.2) by following the manufacturer’s instructions 
(details are described in ref. 8).  
CRITICAL. We regularly check the absence of mycoplasma 
contamination using a commercially available kit such as LookOut 
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Mycoplasma PCR Detection Kit (Sigma-Aldrich, cat. no. MP0035) or 
MycoAlert Mycoplasma Detection Kit (Lonza, cat. no. LT07-118). 
CAUTION The authenticity of the cell line and absence of 
mycoplasma infection should be regularly tested.  
• DMEM (e.g. Thermo Fisher Scientific, cat. no. 10569010) 
• FBS (Thermo Fisher Scientific, cat. no. 10500064) 
• PBS (e.g. Thermo Fisher Scientific, cat. no. 10010056) 
• Nuclease-free water (e.g. Thermo Fisher Scientific, cat. no. 10977049) 
• Doxycycline (Sigma-Aldrich, cat. no. D9891) 
[Caution] Doxycycline is harmful if swallowed, and causes skin 
irritation. 
• Blasticidin S HCl (10 mg ml-1; Thermo Fisher Scientific, cat. no. A1113903) 
[Caution] Blasticidin S HCl is fatal if swallowed, and harmful 
in contact with skin 
• Hygromycin B (100 mg ml-1; InvivoGen; standard Hygromycin B has been 
discontinued, and replaced by Hygromycin B Gold, cat. no. ant-hg-1) 
[Caution] Hygromycin B is fatal if swallowed or in contact with skin 
• 5′ DNA adenylation kit (NEB, cat no. E2610). Supplied with Mth RNA ligase 
(50 pmol µl-1), 5′ DNA adenylation reaction buffer (10×), and ATP (1 mM) 
• Acid-phenol:chloroform (pH 4.5; Thermo Fisher Scientific, cat. no. AM9722) 
[Caution]  Phenol is corrosive. Phenol must be used in a fume hood 
with gloves and other necessary protections 
• Linear acrylamide (5 mg ml-1; Thermo Fisher Scientific, cat. no. AM9520) 
• Sodium acetate (3 M, pH 5.5; Thermo Fisher Scientific, cat. no. AM9740)  
• 15% Novex TBE-Urea gels, 10 well (Thermo Fisher Scientific, cat. no.  
EC6885BOX) 
• Ethanol (Sigma-Aldrich, cat. no. 24102) 
[Caution] Ethanol is flammable. 
• SYBR green II (Thermo Fisher Scientific, cat. no. S7564) 
• SYBR safe (Thermo Fisher Scientific, cat. no. S33102) 
• Dynabeads antibody coupling kit (Thermo Fisher Scientific, cat. no. 14311D) 
• Tris-HCl (1 M, pH 6.5 / 7.4 / 7.8; dissolved e.g. Fisher Scientific, cat. no. 
BP152-1 in nuclease-free water and adjusted the pH by adding e.g. Sigma-
Aldrich, cat. no. 31087) 
• NaCl (5M; dissolved Sigma-Aldrich, cat. no. S7653 in nuclease-free water) 
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• EDTA (100 mM; diluted from Thermo Fisher Scientific, cat. no. 15575020) 
• MgCl2 (1 M; e.g. Thermo Fisher Scientific, cat. no. AM9530G) 
• Protease Inhibitor Cocktail Set III (Calbiochem, cat. no. 539134) 
• Igepal CA-630 (Sigma-Aldrich, cat. no. I8896) 
• SDS (Sigma-Aldrich, cat. no. L3771) 
• Sodium deoxycholate (Sigma-Aldrich, cat. no. D6750) 
• Triton X-100 (e.g. Sigma-Aldrich, cat. no. T8787) 
• DTT (e.g. Sigma-Aldrich, cat. no. DTT-RO ROCHE) 
• RNase I (100 U μl-1; Thermo Fisher Scientific, cat. no. AM2294) 
• RNasin Ribonuclease Inhibitor (20 – 40 U μl-1; Promega, cat. no. N2115) 
• RNasin Plus RNase inhibitor (40 U μl-1; Promega, cat. no. N2615) 
• SUPERaseIn RNase inhibitor (20 U μL-1; Thermo Fisher Scientific, cat. no. 
AM2694) 
• TURBO DNase (2 U µl-1; Thermo Fisher Scientific, cat. no. AM2238) 
• ANTI-RNase (15-30 U µl-1; Thermo Fisher Scientific, cat. no. AM2690) 
• T4 PNK (10 U µl-1; NEB, cat. no. M0201). Supplied with PNK buffer (10×) 
• T4 RNA ligase 2, truncated K227Q (200 U µl-1; NEB, cat. no. M0351) 
• PEG400 (Sigma-Aldrich, cat. no. 81170) 
• T4 RNA Ligase 1 (ssRNA Ligase) (NEB, cat. no. M0204). Supplied with T4 
RNA ligase reaction 1 buffer  (10×; B0216S) 
[Critical] Must use the ligation buffer that does not contain ATP  
• Urea (Sigma-Aldrich, cat. no. U5378) 
• Dynabeads Protein G (Thermo Fisher Scientific, cat. no. 10004D) 
• Anti-FLAG M2 antibody (1 mg ml-1; Sigma-Aldrich, cat. no. F1804) 
• 32P-γ-ATP (10 mCi ml-1; PerkinElmer, cat. no. NEG002A250UC) 
[Caution] 32P-γ-ATP is radioactive. Radioactive materials should be 
used by following the governmental and local regulations, and be handled 
with appropriate protections and care. 
• NuPAGE LDS sample buffer (4×; Thermo Fisher Scientific, cat. no. NP0007) 
• NuPAGE sample reducing agent (Thermo Fisher Scientific, cat. no. NP0004) 
• 4-12% NuPAGE Bis-Tris gel, 1.0 mm, 10-well (Thermo Fisher Scientific, cat. 
no. NP0321BOX) 
[Critical] Choose 1.0 mm and 10-well gels since thicker gels are less 
efficient when transferring protein-RNA complexes to nitrocellulose 
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membranes and wider wells give better separation of protein-RNA 
complexes during electrophoresis 
• MOPS running buffer (20×; Thermo Fisher Scientific, cat. no. NP0001) 
• Methanol (e.g. Thermo Fisher Scientific, cat. no. A412-1) 
• NuPAGE antioxidant (Thermo Fisher Scientific, cat. no. NP0005) 
• PageRuler Plus prestained protein ladder (Thermo Fisher Scientific, cat. no. 
SM1811) 
• Protran BA85 nitrocellulose membrane (Whatman. cat. no. BA85) 
• NuPAGE Transfer Buffer (20×; Thermo Fisher Scientific, cat. no. NP00061) 
• Carestream Kodak BioMax XAR film (Sigma-Aldrich, cat. no. Z358487) 
• Proteinase K (Roche cat. no. 03115828001) 
• Superscript III RT (200 U µl-1; Thermo Fisher Scientific, cat. no. 18080-044). 
Supplied with First-Strand Buffer (5×) and DTT (0.1 M) 
• dNTP mix (10 mM; e.g. Thermo Fisher Scientific, cat. no. 18427-013) 
• NaOH (1 M; Diluted from Sigma-Aldrich, cat. no. 221465) 
[Caution] NaOH causes severe burn in contact with skin. 
NaOH must be used in a fume hood with gloves and other necessary 
protections 
• HEPES-NaOH (1 M; Thermo Fisher Scientific, cat. no. BP299-500) 
• Novex TBE-Urea sample buffer (2×; Thermo Fisher Scientific, cat. no. 
LC6876) 
• 6% Novex TBE-Urea gels, 10 well (Thermo Fisher Scientific, cat. no. 
EC6865BOX) 
• CircLigase II ssDNA ligase (100 U µl-1; Epicentre, cat. no. CL9025K). 
Supplied with CircLigase II reaction buffer (10×) and MnCl2 (50 mM) 
• FastDigest BamHI (Thermo Fisher Scientific, cat. no. FD0055). Supplied with 
FastDigest buffer (10×) 
• Accuprime Supermix I enzyme (Thermo Fisher Scientific, cat. no. 12342010) 
• 6% Novex TBE gels (e.g. Thermo Fisher Scientific, cat. no. EC6265BOX) 
• Sample loading dye (5×; Bio-Rad, cat. no. 1660401) 
• AMpure XP (Beckman Coulter, cat. no. A63880) 
• Platinum Quantitative PCR SuperMix-UDG w/ROX (Thermo Fisher Scientific, 
cat. no. 11743500) 
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• Oligonucleotide (See Table 1; custom order from Integrated DNA 
Technologies except DLP oligo and qPCR primer 1 and 2, which are custom 
order from Sigma-Aldrich)  
 
EQUIPMENT 
• 15 cm cell culture dishes (e.g. Sigma-Aldrich, cat. no. CLS430599)  
• Cell lifters (e.g. Corning, cat. no. 3008) 
• 1.5 ml microfuge tubes (Nonstick, RNase-free; Thermo Fisher Scientific, cat. 
no. AM12450) 
• 50 ml conical centrifuge tubes (e.g. Thermo Fisher Scientific, cat. no. 14-432-
22) 
• 0.2 ml PCR tubes (e.g. Corning, cat. no. AXY-PCR-02-C) 
• 2 ml Phase Lock Gel Heavy tube (VWR, 713-2536) 
• 1 cm Glass filters (Whatman, cat. no. 1823010) 
• Costar SpinX column (Corning, cat. no. 8161) 
• 96-well plate for qPCR (e.g. Thermo Fisher Scientific, cat. no. 4346906) 
• Optical adhesive film (e.g. Thermo Fisher Scientific, cat. no. 4311971) 
• Rotating wheels for 50 ml conical tubes and 1.5 ml microfuge (e.g. Stuart, cat. 
no. SB3) 
• Squisher-Single (To crush gel pieces; Zymo Research, cat. no. H1001-50) 
• 0.45 µm syringe filter (e.g. Millipore, cat. no. SLHV033RS) 
• 50 ml disposable syringe (e.g. VWR, cat. no. 97048-662) 
• 21G needle (e.g. Greiner Bio-One, cat. no. 450072) 
• Refrigerated centrifuge for 50 ml conical centrifuge tubes (e.g. Eppendorf, 
cat. no. 5810R) 
• Tabletop refrigerated centrifuge for 1.5 ml microfuge tubes (Maximum RCF 
should be ≥ 21,040g; e.g. Eppendorf, cat. no. 5424R)  
• Thermal cycler (e.g. Bio-Rad, cat. no. 1851148) 
• qPCR machine (compatible with the following method: detector: FAM-TAMRA 
and passive reference: ROX; e.g. Thermo Fisher Scientific, cat. no. 4485697) 
• NanoDrop (e.g. Thermo Fisher Scientific, cat. no. ND-2000) 
• Thermomixer Comfort (Eppendorf, cat. no. 5355 000.011) or Thermomixer 
Compact (Eppendorf, cat. no. 5350 000.013) 
• UV transilluminator (e.g. Bio-Rad, cat. no. 1708195) 
• Vortex (e.g. Scientific Industries, cat. no. SI-0236) 
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• Cling Film (e.g. Fisher Scientific, cat. no. 12872233) 
• Scintillation counter (To monitor radioactivity; e.g. Fisher Scientific, Mini 900 
Scintillation Monitors) 
• Fluor-Coated TLC Plate (10 × 10 cm) (Thermo Fisher Scientific, cat. no. 
AM10110) 
• Handheld 254 nm UV light (for UV shadowing; e.g. UVP, cat. no. 95-0007-05) 
• UV crosslinker (e.g. Stratagene, Stratalinker 2400) 
• Tray that can be put in the UV crosslinker (Dimensions: 409mm × 300mm × 
42 mm; to place cell culture dishes on ice during UV-C crosslinking; e.g. 
Kartell, 5714) 
• XCell SureLock Mini-Cell with XCell II blot module kit (For electrophoresis 
and membrane transfer. Power supply unit is also needed; Thermo Fisher 
Scientific, cat. no. EI0002) 
• Magnetic stand (e.g. DynaMag-2 Magnet, Thermo Fisher Scientific, cat. no. 
12321D) 
• MiSeq Gene & Small Genome Sequencer (illumina) 
• MiSeq Reagent Kit that is compatible to sequence more than 200 bases in a 
single read (e.g. illumina, cat. no. MS-102-2002) 
• 64-bit computer running either Linux or Mac OS X (tested on 10.11); 16 GB 
RAM (> 32 GB preferred); 4 cores (> 8 preferred)  
• Installation of the “hiclipr” R package (from https://github.com/luslab/hiclipr) 
and dependencies as detailed in Box 1.  
 
REAGENT SETUP 
TE buffer. 100 mM Tris-HCl (pH 7.4), 10 mM EDTA in nuclease-free water. To 
prepare 1 l of TE buffer, mix 100 ml of 1 M Tris-HCl (pH 7.4), 100 ml of 100 mM 
EDTA, and 800 ml of nuclease-free water. This buffer can be stored at room 
temperature (20–25˚C) for up to several months unless otherwise specified.  
 
CLIP lysis buffer. 50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1% (vol/vol) Igepal 
CA-630, 0.1% (wt/vol) SDS, 0.5% (wt/vol) sodium deoxycholate in nuclease-free 
water. To prepare 1 l of CLIP lysis buffer, mix 50 ml of 1 M Tris-HCl (pH 7.4), 20 ml 
of 5M NaCl, 10 ml of Igepal CA-630, 10 ml of 10% (wt/vol) SDS, and 50 ml of 10% 
(wt/vol) sodium deoxycholate, and add nuclease-free water so that the final volume 
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will be 1 l. This buffer is filtered using a 0.22 µm vacuum filter unit, and can be 
stored at 4˚C for up to several months. 
 
High-salt wash. High-salt wash contains 50 mM Tris-HCl (pH 7.4), 1 M NaCl, 1 mM 
EDTA, 1% (vol/vol) Igepal CA-630, 0.1% (wt/vol) SDS, and 0.5% (wt/vol) sodium 
deoxycholate in nuclease-free water. In order to prepare 1 l of high-salt wash, mix 50 
ml of 1 M Tris-HCl (pH 7.4), 200 ml of 5M NaCl, 10 ml of 100 mM EDTA, 10 ml of 
Igepal CA-630, 10 ml of 10% (wt/vol) SDS, and 50 ml of 10% (wt/vol) sodium 
deoxycholate, and add nuclease-free water so that the final volume will be 1 l. This 
buffer is filtrated using a 0.22 µm vacuum filter unit, and can be stored at 4˚C for up 
to several months. 
 
PG cell lysis buffer. PG cell lysis buffer contains 20 m Tris-HCL (pH 7.4), 140 mM 
NaCl, 5 mM MgCl2, and 1% (vol/vol) Triton-X 100 in nuclease-free water. In order to 
prepare 1 l of PG cell lysis buffer, mix 20 ml of 1 M Tris-HCl (pH 7.4), 28 ml of 5M 
NaCl, 5 ml of 1 M MgCl2, and 10 ml of Triton-X 100, and add nuclease-free water so 
that the final volume will be 1 l. This buffer is filtrated using a 0.22 µm vacuum filter 
unit, and can be stored at 4˚C for up to several months. 
 
DTT solution (1M). Dissolve 1.54 g of DTT in 10 ml of nuclease-free water. Aliquot 
100 µl or 1 ml per tube. This buffer can be stored at -20 ˚C for up to several months, 
but avoid repeated freeze-thaw cycles. 
 
PG cell lysis buffer complete. Mix PG cell lysis buffer with 1 mM DTT, 1/1,000 
(vol/vol) anti-RNase, 4/1,000 (vol/vol) Protease Inhibitor Cocktail Set III, and 
1/10,000 (vol/vol) TURBO DNase. This buffer should be freshly prepared before use, 
and kept on ice. 
 
Urea cracking buffer (1.25×). Urea cracking buffer (1.25×) contains 66.6 mM Tris-
HCl, 8M urea, 1.33% SDS, and 31.25% (vol/vol) PBS in nuclease-free water. In order 
to prepare 10 ml of urea cracking buffer (1.25×), mix 666 µL of 1 M Tris-HCl (pH 
7.4), 1.33 ml of 10% (wt/vol) SDS, 3.125 ml of PBS, and 4.8 g of urea, and add 
nuclease-free water so that the final volume will be 10 ml. Aliquot 1 ml per tube. This 
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buffer can be stored at -20 ˚C for up to several months, but avoid repeated freeze-
thaw cycles. 
 
T-20 IP buffer. T-20 IP buffer contains 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 
0.1 mM EDTA, and 0.5% (vol/vol) Tween-20 in nuclease-free water. In order to 
prepare 1 l of T-20 IP buffer, mix 50 ml of 1 M Tris-HCl (pH 7.4), 30 ml of 5M NaCl, 
1 ml of 100 mM EDTA, and 5 ml of Tween-20, and add nuclease-free water so that 
the final volume will be 1 l. This buffer is filtrated using a 0.22 µm vacuum filter unit, 
and can be stored at 4˚C for up to several months. 
 
PNK buffer. PNK buffer contains 20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 0.2% 
(vol/vol) Tween-20 in nuclease-free water. In order to prepare 1 l of PNK buffer, mix 
20 ml of 1 M Tris-HCl (pH 7.4), 10 ml of 1M MgCl2, and 2 ml of Tween-20, and add 
nuclease-free water so that the final volume will be 1 l. This buffer is filtrated using a 
0.22 µm vacuum filter unit, and can be stored at 4˚C for up to several months. 
 
PNK pH 6.5 buffer (5×). PNK pH 6.5 buffer (5×) contains 350 mM Tris-HCl (pH 
6.5), 50 mM MgCl2, and 25 mM DTT in nuclease-free water. In order to prepare 1 ml 
of PNK pH 6.5 buffer (5×), mix 350 µl of 1M Tris-HCl (pH 6.5), 50 µl of 1M MgCl2, 
25 µl of 1M DTT, and 575 µl of nuclease-free water. Aliquot 100 µl per tube. This 
buffer can be stored at -20 ˚C for up to 1 year, but avoid repeated freeze-thaw cycles. 
 
Ligation buffer (4×). Ligation buffer (4×) contains 200 mM Tris-HCl (pH 7.8), 40 
mM MgCl2, and 40 mM DTT in nuclease-free water. In order to prepare 1 ml of 
ligation buffer (4×), mix 200 µl of 1 M Tris-HCl (pH 7.8), 40 µl of 1 M MgCl2, 40 µl 
of 1 M DTT, and 720 µl of nuclease-free water. Aliquot 100 µl per tube. This buffer 
can be stored at -20 ˚C for up to 1 year, but avoid repeated freeze-thaw cycles. 
 
PK buffer. PK buffer contains 100 mM Tris-HCl (pH 7.4), 50 mM NaCl, and 10 mM 
EDTA in nuclease-free water. In order to prepare 1 l of PK buffer, mix 100 ml of 1 M 
Tris-HCl (pH 7.4), 50 ml of NaCl, 100 ml of 100 mM EDTA, and 750 ml of nuclease-
free water. This buffer is filtrated using a 0.22 µm vacuum filter unit, and can be 
stored at 4˚C for up to several months. 
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PK buffer with 7M urea. PK buffer with 7M urea contains 100 mM Tris-HCl (pH 
7.4), 50 mM NaCl, 10 mM EDTA, and 7M urea in nuclease-free water. In order to 
prepare 10 ml of PK buffer with 7M urea, mix 1 ml of 1 M Tris-HCl (pH 7.4), 100 µl 
of NaCl, 1 ml of 100 mM EDTA, and 4.2 g of urea, and add nuclease-free water so 
that the final volume will be 10 ml. Aliquot 1 ml per tube. This buffer can be stored at 
-20 ˚C for up to several months, but avoid repeated freeze-thaw cycles. 
 
Box 1: Downloading and installing software; Timing variable; ~1 hour 
 
The hiCLIP analysis pipeline is available as an R (3.2.4) package “hiclipr” designed 
to be run in a UNIX environment (e.g. Linux or Mac OS X). 
 
1. Download the "hiclipr" package (hiclipr_0.3.tar.gz) from 
https://github.com/luslab/hiclipr.  
2. Within R, ensure the package dependencies are installed. Each command is 
prefixed here with the R command prompt “>” which does not need to be entered. 
> install.packages(c("ggplot2", "rentrez", "data.table")) 
> source("https://bioconductor.org/biocLite.R") 
> biocLite(c("BiocGenerics", "Biostrings", "BSgenome.Hsapiens.UCSC.hg19", 
"GenomicAlignments", "GenomicRanges", "IRanges", "rtracklayer", 
"ShortRead")) 
3. Install the “hiclipr” package 
> install.packages("path/to/hiclipr.tar.gz", repos = NULL, type = "source") 
4. The hiCLIP analysis pipeline and “hiclipr” also requires the following programs to 
be installed according to the developer’s instructions: 
   Bowtie (1.1.2)42 from http://bowtie-bio.sourceforge.net/index.shtml 
   Samtools (1.3)43 from https://github.com/samtools/samtools 
   Sambamba (0.6.3)44 from https://github.com/lomereiter/sambamba 
   Cutadapt (1.9.1)45 from http://cutadapt.readthedocs.io/en/stable/ 
   RNAhybrid (2.1.2)46 from http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/ 
   CRITICAL. Ensure the executable files are named: “bowtie”, “samtools”, 
“sambamba”, “cutadapt” and “RNAhybrid” respectively. 
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5. Add these programs to the “PATH” environment variable using the appropriate 
method for the operating system. 
END OF BOX 1 
 
 
PROCEDURE 
[Preparation of adaptors; Timing 2h (plus overnight and ~5h the following day)] 
1. Set up two adenylation reaction mixes as below: one for RNA adaptor A and one 
for RNA adaptor B. 
 
Component Amount (µl) Final concentration 
RNA adaptor A or RNA adaptor B (100 µM) 10 5 µM 
5ʹ  DNA adenylation reaction buffer (10×) 20 1× 
ATP (1 mM) 20 0.1 mM 
Nuclease-free water 130 
 Mth RNA ligase (50 pmol µl-1) 20 5 µM  
Total 200   
 
[Critical Step] We purchase RNA adaptors with a 5´ phosphate, and adenylate 
the 5´ end with the protocol described from Step1 to Step 22. We usually 
adenylate 1 nmol of RNA adaptor A or RNA adaptor B in a single experiment.  
 
2. Split the reaction mix into ten 200 µl PCR tubes (20 µl per tube), and incubate 
for 1 h at 65˚C in a thermal cycler. 
 
3. For each adaptor, pool samples in a 1.5 ml microfuge tube and add 200 µl of TE 
buffer (the final volume is 400 µl).  
 
4. Add 400 µl of acid-phenol:chloroform (pH 4.5) to each sample, and transfer to a 
2 ml Phase Lock Gel Heavy tube. 
 
5. Invert the samples 10 times, and then centrifuge at room temperature for 5 min at 
15,700g to separate the aqueous and organic phases. 
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6. For each sample, transfer the aqueous phase to a new 1.5 ml microfuge tube, and 
add 1 µl of linear acrylamide and 40 µl of sodium acetate (3M, pH 5.5) to it. 
 
7. Add 1 ml of ethanol to each sample, and vortex. 
  
8. Incubate the samples overnight at -20 °C to precipitate RNA. 
 
9. Next day, centrifuge the samples at 4 °C for 15 min at > 20,000g to pellet RNA, 
and then discard the supernatant. 
 
10. Add 1 ml of 80% (vol/vol) ethanol to wash the RNA pellet, vortex, and then 
centrifuge at 4 °C for > 5 min at > 20,000g to pellet RNA again. 
 
11. Discard the supernatant and air-dry the RNA pellet for 3 min. 
 
12. Resuspend the RNA pellet in 6 µl of nuclease-free water. 
[Pause Point] The purified RNA adaptors can be stored for at least a month at -
80 ˚C. 
 
13. Add 6 µl of Novex TBE-Urea sample buffer (2×) to each sample. Also as a 
control, prepare two samples containing 100 ng of non-adenylated RNA Adaptor  
in 12 µL of Novex TBE-Urea sample buffer (one for Adaptor A and one for 
Adaptor B). 
 
14. Incubate the samples for 5 min at 80 °C to denature RNA, and then place on ice. 
 
15. Load the samples and control samples on a 15% Novex TBE-Urea Gels (10 well), 
and perform electrophoresis for 70 min at 180 V using a XCell SureLock Mini-
Cell by following the manufacturer’s instruction. As a control, non-adenylated 
adaptors can be loaded together with the samples to determine the expected 
migration in the gel.  
[Critical step] In order to facilitate the excision of bands, load samples in 
alternate wells.  
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16. Visualize the RNA adaptor in the gel using UV shadowing, and purify the 
adaptor from the gel. In detail, cover a Fluor-Coated TLC Plate with saran wrap 
and place the gel on top of it. Then irradiate the gel using a handheld 254 nm UV 
light. The gel region containing RNA will be darker47. Excise the gel regions 
corresponding to the adenylated adaptor, and put the gel pieces into a new 1.5 ml 
microfuge tube. 
[Critical step] In order to minimize the damage to RNA adaptors, UV light 
exposure time should be as short as possible.  
[Critical step] Only the band corresponding to the adenylated adaptors should be 
excised. The band from adenylated adaptor migrates 1nt higher than the non-
adenylated adaptor. Using the conditions described here, the adenylation 
efficiency should be > 90% (Fig. 6). 
? Troubleshooting 
 
17. Add 400 µl of TE buffer and 1 µl of RNasin (20-40 U μl-1) to the gel pieces, and 
crush them using a Squisher-Single. 
 
18. Incubate the samples at 37°C for 1 h at 1,100 rpm shaking in a Thermomixer. 
Place them on dry ice for 2 min, and then incubate again at 37°C for 1 h at 1,100 
rpm shaking in a Thermomixer. 
 
19. For each sample, place two 1 cm glass filters in a Costar SpinX column, and 
transfer the liquid portion of the sample into the column. 
 
20. Centrifuge the columns at 15,700g for 1 min at room temperature to remove any 
remaining gel pieces, and transfer the filtered sample to a new 1.5 ml microfuge 
tube. 
 
21. Perform acid phenol-chloroform-isoamyl alcohol (PCI) extraction and ethanol 
precipitation as described in Step 4-11.  
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22. Resuspend each RNA pellet in 25 µl of nuclease-free water, and quantify the 
wt/vol concentration of the sample using NanoDrop or similar. Add nuclease-
free water to each sample to a final concentration of 10 µM. 
[Critical Step] In hiCLIP, it is important to have equimolar amounts of RNA 
adaptor A and B in the first round of ligation (Step 52-53), since unequal 
concentrations may result in a smaller proportion of hybrid reads in the final 
library. Thus, the molar concentration of the adaptors must be carefully adjusted 
using the wt/vol concentration measured by NanoDrop (or a similar device) and 
the expected molecular weight of the adaptors (around 6,500 and 7,100 for RNA 
Adaptor A and B respectively). 
[Pause Point] The purified RNA adaptors can be stored for at least a month at -
80 ˚C. 
 
[Preparation of cells and UV crosslinking; Timing ~2 days] 
23. Culture FLAG-STAU1-Flp-In 293 T-REx cells on 15 cm dishes in DMEM 
containing 10% (vol/vol) FBS, blasticidin S HCl (3 µg µl-1), and hygromycin B 
(200 µg µl-1) to 60-70% confluent. Add doxycycline (final concentration 250 ng 
ml-1) to the medium in order to induce the FLAG-STAU1 expression. We 
generally use cells from five 15 cm dishes for each hiCLIP or control sample. 
For example, two hiCLIP samples and two negative control samples (without 
second ligation and without FLAG tagged STAU1 expression) would require 
twenty 15 cm dishes. 
 
24. 16 h after induction, transfer the dishes to ice and remove the medium from them.  
 
25. For each dish, wash the cells with 10 ml of ice-cold PBS, and then add 10 ml of 
ice-cold PBS. 
 
26. Place the dishes on an ice-filled tray and remove the lids. Put them in a UV 
crosslinker (Stratlinker 2400). We generally crosslink cells on 3 dishes at once. 
 
27. Irradiate the cells once with UV light (150 mJ/cm2 at 254 nm) to crosslink 
proteins and RNAs. 
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28. Scrape the cells from the dishes using cell lifters, and pool the cell suspension in 
a 50 ml conical tube (The cells from 5 dishes are pooled in a single tube). 
 
29. Centrifuge the tubes at 514g for 5 min at 4 °C to pellet the cells, and discard the 
supernatant. 
 
30. Snap-freeze the cell pellets by placing the tubes on dry ice, and store at -80 °C.  
[Pause point] Frozen cells can be stored at -80 ˚C for at least a month. 
 
[Preparation of antibody-coupled beads; Timing 4 h] 
31. Covalently couple 300 µg of anti-FLAG M2 antibody with 10 mg of Dynabeads 
using Dynabeads antibody coupling kit by following the manufacturer’s 
instruction. After the coupling, we resuspend 10 mg of beads in 1 ml of the 
buffer supplied with the kit. 
 
32. Transfer 100 µl per sample of antibody-coupled beads to a new 1.5 ml microfuge 
tube, and discard the supernatant using a magnetic stand. We prepare the beads 
for up to 4 samples in one 1.5 ml microfuge tube. 
 
33. Wash the antibody-coupled beads once with 1 ml of CLIP lysis buffer, and twice 
with 1 ml of high-salt wash. After each wash, discard the supernatant using a 
magnetic stand. After the final wash, resuspend the beads in 100 µl per sample of 
PG cell lysis buffer, and then store the beads at 4 ˚C. 
[Pause point] Antibody-coupled beads can be stored at 4 ˚C for a week. 
 
[Cell lysis and partial RNA digestion; Timing 2 h] 
34. Add 30 ml of ice-cold PG cell lysis buffer complete to the cell pellet in a 50 ml 
conical tube. For a single hiCLIP sample, we generally use the cell pellets in a 50 
ml conical tube (i.e. cells from five 15 cm dishes). 
[Critical step] After cell lysis, care should be taken to avoid RNA degradation. 
The equipment should be kept RNase-free. Keep samples on ice, and use ice-
cold buffer unless otherwise specified.  
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35. For each lysate from a 50 ml conical tube, pass it through a syringe needle twice 
using a 21G needle and 50 ml disposable syringe, and collect the sample in a 
new 50 ml conical tube. 
 
36. Centrifuge the tubes at 14,000g for 5 min at 4 ˚C, and transfer the supernatant to 
a new 50 ml conical tube. Repeat this clarification step once more. 
 
37. Add 20 ml of ice-cold PG cell lysis buffer to the lysate to bring the final volume 
of each sample to 50 ml, filter the sample using a 0.45 µm syringe filter and a 50 
ml disposable syringe, and collect in a new 50 ml conical tube. 
[Critical Step] The lysate is diluted to facilitate filtration. The filter should be 
replaced if there is clogging. We generally use 2 filters to process 50 ml of 
sample. 
? Troubleshooting 
 
38. Add 2 µl or 1 µl of RNase I (original concentration 100,000 U ml-1) for a final 
concentration of 4 U ml-1 (high-RNase condition) or 2 U ml-1 (low-RNase 
condition), respectively to each sample.  
[Critical step] Digest RNA to a suitable length for sequencing. We generally 
perform hiCLIP experiments with multiple RNase I concentrations as described 
here. The optimal condition should be tested for new experimental setups (see 
“partial RNA digestion” section of Experimental design). 
 
39. Incubate the samples for 5 min at 37 °C in water bath agitating by hand. After 
incubation, immediately transfer the samples to ice, and add 20 µl of 
SUPERaseIn RNase inhibitor (10 U µl-1). After mixing, leave the sample on ice 
for 5 min. 
[Critical step] SUPERaseIn RNase inhibitor is used to inhibit RNase I activity. 
 
[First round of immunoprecipitation; Timing 3-4 h] 
40. For each hiCLIP sample, transfer 100 µl of the antibody-coupled beads to a new 
1.5ml microfuge tube, discard the supernatant using a magnetic stand, and 
   
29 of 56 
resuspend the beads in 1 ml of PG cell lysis buffer. 
[Critical step] The amount of beads used for immunoprecipitation may need to 
be adjusted depending on the antibody and the target protein.  
 
41. Add the antibody-coupled beads in 1 ml of PG cell lysis buffer to each cell lysate 
from step 39. 
 
42. Incubate the beads/lysate mix for 2-3 h at 4 °C on a rotating wheel. 
 
43. Centrifuge the samples at 800g for 5 min at 4 ºC to pellet the beads, and discard 
the supernatant.  
 
44. Add 500 µl of PG cell lysis buffer to resuspend the beads, and transfer them to a 
new 1.5 ml microfuge tube. 
 
45. Discard the supernatant using a magnetic stand. 
 
46. Wash the beads twice with 1 ml of PG cell lysis buffer. After each wash, discard 
the supernatant using a magnetic stand. For the second wash, incubate the 
mixture at 4 ˚C for 1 min on a rotating wheel. 
 
47. Add 1 ml of PG cell lysis buffer with 2 µl of TURBO DNase (2 U µl-1), 1 µl of 
RNasin Plus RNase inhibitor (40 U μl-1) and, 1 µl of SUPERaseIn RNase 
inhibitor (20 U μl-1) to each sample. Incubate the samples at 37 ºC for 3 min at 
1,100 rpm, shaking in a Thermomixer. 
[Critical step] This step ensures that any residual DNA is removed. 
 
48. Wash the beads twice with 1 ml of PG cell lysis buffer, and three times with 
PNK buffer. After each wash, discard the supernatant using a magnetic stand. 
For the second wash with PG cell lysis buffer, incubate the mixture at 4 ˚C for 1 
min with rotating. 
 
[3ʹ  end dephosphorylation; Timing 1 h] 
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49. For each sample, resuspend the beads in 20 µl of PNK reaction mix as tabulated 
below, and incubate at 37 ˚C for 20 min at 1,100 rpm shaking in a Thermomixer: 
 
Component Amount (µl) Final concentration 
PNK pH 6.5 buffer (5×) 4 1× 
Nuclease-free water 14.5 
 RNasin Plus RNase inhibitor (40 U μl-1) 0.5 1 U µL-1 
SUPERaseIn RNase inhibitor (20 U µl-1) 0.5 0.5 U µL-1 
T4 PNK (10 U µl-1) 0.5 0.25 U µL-1 
Total 20   
 
 
50. Wash the beads once with 1 ml of PNK buffer, twice with 1 ml of PG cell lysis 
buffer, and three times with 1 ml of PNK buffer. For the washes with PG cell 
lysis buffer, incubate at 4 ˚C for 5 min on a rotating wheel. After each wash, 
discard the supernatant using a magnetic stand.  
 
[First round of ligation (adaptor ligation); Timing 30 min (plus overnight and 30 min 
the following day)] 
51. For each sample, resuspend the beads in 20 µl of first round ligation reaction mix 
as tabulated below, and incubate at 16 °C overnight at 1,100 rpm shaking in a 
Thermomixer. 
 
Component Amount (µl) Final concentration 
Ligation buffer (4×) 4 0.8× 
Nuclease-free water 6 
 PEG400 4 20% (vol/vol) 
Pre-adenylated RNA adaptor A (10 µM; from Step 23) 2 1 µM 
Pre-adenylated RNA adaptor B (10 µM; from Step 23) 2 1 µM 
RNasin Plus RNase inhibitor (40 U μl-1) 0.5 1 U µL-1 
SUPERaseIn RNase inhibitor (20 U µl-1) 0.5 0.5 U µL-1 
T4 RNA ligase 2, truncated K227Q (200 U µl-1) 1 10 U µL-1 
Total 20   
 
[Critical] We found that T4 RNA ligase 2, truncated K227Q is more specific and 
efficient at ligating the adenylated RNA adaptor to RNA than T4 RNA ligase 1 
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(data not shown, YS). 
 
52. Wash the beads once with 500 µl of PNK buffer, twice with 1 ml of PG cell lysis 
buffer, and once with 1 ml of PNK buffer. For the washes with PG cell lysis 
buffer, incubate the mixture at 4 ˚C for 1 min on a rotating wheel. After each 
wash, discard the supernatant using a magnetic stand. 
 
[5ʹ  end phosphorylation of RNA and removal of adaptor B’s phosphate blocking; 
Timing 1 h] 
53. For each sample, resuspend the beads in 20 µl of PNK reaction mix as tabulated 
below, and incubate at 37°C for 30 min 1,100 rpm shaking in a Thermomixer. 
 
Component Amount (µl) Final concentration 
ATP (10 mM) 2 1 mM 
PNK buffer (10×) 2 1× 
Nuclease-free water 14.5 
 RNasin Plus RNase inhibitor (40 U μl-1) 0.25 0.5 U µL-1 
SUPERaseIn RNase inhibitor (20 U µl-1) 0.25 0.25 U µL-1 
T4 PNK (10 U µL-1) 1 0.5 U µL-1 
Total 20   
 
 
54. Wash the beads once with 1 ml of PNK buffer, twice with 1 ml of PG cell lysis 
buffer, and once with 1 ml of PNK buffer. After each wash, discard the 
supernatant using a magnetic stand. For the second wash with PG cell lysis 
buffer, incubate the mixture at 4 ˚C for 5 min on a rotating wheel.  
 
[Second round of ligation (hybrid generation); Timing 30 min (plus overnight and 30 
min the following day)] 
55. For each sample, resuspend the beads in 100 µl of second round ligation reaction 
mix as tabulated below, and incubate overnight at 16°C at 1,100 rpm shaking in 
a Thermomixer. 
 
Component Amount (µl) Final concentration 
ATP (10 mM) 10 1 mM 
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T4 RNA ligase reaction buffer (10×) 10 1× 
Nuclease-free water 72.5 
 RNasin Plus RNase inhibitor (40 U μl-1) 2 0.8 U μl-1 
SUPERaseIn RNase inhibitor (20 U µl-1) 0.5 0.1 U μl-1 
T4 RNA ligase 1 (10 U µl-1) 5 0.5 U μl-1 
Total 100   
 
[Critical step] The use of RNA ligase 1 is crucial since this ligase can ligate 
RNA without 5ʹ  adenylation.   
 
56. Wash the beads once with 800 µl of PNK buffer, once with 1 ml of high salt 
wash, and once with 1 ml of PNK buffer. After each wash, discard the 
supernatant using a magnetic stand, and after the final wash, resuspend the beads 
in 1 ml of PNK buffer. 
[Pause point] The sample can be kept at 4 ˚C overnight. 
 
[Preparation of antibody-attached beads; Timing 2-3 h] 
57. Transfer 100 µl per sample of Dynabeads Protein G to a new 1.5 ml microfuge 
tube, and discard the supernatant using a magnetic stand. We prepare the beads 
for up to 4 samples in one 1.5 ml microfuge tube. 
 
58. Wash the beads twice with 1 ml of CLIP lysis buffer. After each wash, discard 
the supernatant using a magnetic stand. 
 
59. Resuspend the beads in 100 µl per sample of CLIP lysis buffer with 10 µg per 
sample M2 Flag antibody, and incubate at room temperature for 1-2 h on a 
rotating wheel. 
 
60. Wash the beads twice with 1 ml of CLIP lysis buffer and once with 1 ml of T-20 
IP buffer. After each wash, discard the supernatant using a magnetic stand. After 
the final wash, resuspend the beads in 100 µl per sample of T-20 IP buffer. 
 
[Second round of immunoprecipitation; Timing 3 h] 
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61. For each sample, discard the supernatant from the beads from Step 56. Add 80 µl 
of urea cracking buffer (1.25×), and incubate at 65 ˚C for 3 min at 1,100 rpm 
shaking in a Thermomixer to elute protein-RNA complexes from the beads. 
 
62. Collect the supernatant containing protein-RNA complexes to a new 1.5 ml 
microfuge tube, and mix it with 920 µl of ice-cold T20-IP buffer with 1 µl of 
ANTI-RNase (15-30 U µl-1), 10 µl of Protease Inhibitor Cocktail Set III, and 1 µl 
of SUPERaseIn RNase inhibitor (20 U µl-1). 
 
63. Place the sample on a magnetic stand, and transfer the supernatant to a new 1.5 
ml microfuge tube. 
[Critical Step] This step is required to remove any residual beads. 
 
64. Add 100 µl of antibody attached beads from Step 60 to each sample, and 
incubate at 4 ˚C for 2 h on a rotating wheel. 
 
65. Wash the beads twice with 1 ml of high salt wash, and once with 1 ml of PNK 
buffer. After each wash, discard the supernatant using a magnetic stand, and after 
the final wash, resuspend the beads in 1 ml of PNK buffer. 
 
[Radiolabelling of RNA; Timing 30 min] 
 
66. For each sample, transfer 200 µl of the beads (20% of all beads) from Step 65 to 
a new 1.5 ml microfuge tube, and discard the supernatant. Resuspend the beads 
in 4 µl of hot-PNK reaction mix as tabulated below, and incubate at 37 ˚C for 5 
min at 1,100 rpm shaking in a Thermomixer.  
[Critical steps] Radiolabelling of RNA is very efficient. In order to minimize the 
radioactivity of samples, we only radiolabel 20% of a sample, and mix it together 
with the remaining 80% at Step 68. 
 
Component Amount (µl) Final concentration 
32P-γ-ATP (10 mCi ml-1) 0.4 1 mCi ml-1 
PNK buffer (10×) 0.4 1× 
Nuclease-free water 3 
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T4 PNK (10 U µl-1) 0.2 0.5 U µl-1 
Total 4   
 
 
67. Discard the supernatant, and add 20 µl of NuPAGE LDS sample buffer (1×) with 
NuPAGE sample reducing agent (1×) to the radiolabelled beads.  
 
[SDS-PAGE, nitrocellulose membrane transfer, and autoradiography; Timing 3h] 
68. For each sample, discard the supernatant from 800 µl of the remaining beads 
(80% of all beads) from Step 65. Add the radiolabelled beads in 20 µl of the 
buffer from Step 67 to it, and mix.  
 
69. Incubate the samples at 70°C for 5 min at 1,100 rpm shaking in a Thermomixer, 
and transfer the supernatant to new 1.5 ml microfuge tubes using a magnetic 
stand. 
 
70. Load the supernatant on a 4-12% NuPAGE Bis-Tris gel and perform 
electrophoresis for 45 min at 180 V using a XCell SureLock Mini-Cell with 
MOPS running buffer (1×) and 500 µl of NuPAGE antioxidant by following the 
manufacturer’s instruction. We also run 5 μl of PageRuler Plus prestained 
protein ladder on the last lane as a protein size marker.  
[Critical step] In order to facilitate excision of membrane, load samples in 
alternate wells. 
 
71. Remove the gel cassettes from the tank and open the cassettes. Cut out and 
discard the part of the gel containing the dye front.  
[Caution] This contains free 32P-γ-ATP, which is highly radioactive. Discarding 
this part can minimize the radioactivity of materials handled at later steps. 
 
72. Transfer the protein-RNA complexes from the gel to a Protan BA85 
nitrocellulose membrane at 30V for 1 h using a XCell SureLock Mini-Cell and 
XCell IITM blot module kit with NuPAGE transfer buffer (1×) and methanol 
(10%; vol/vol) by following the manufacturer’s instructions. 
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[RNA isolation; Timing ~4 h (plus overnight and 1h the following day)] 
73. Take out the membrane from the apparatus. Cover the membrane with saran 
wrap, and expose it to a Carestream Kodak BioMax XAR Film at -80 °C for 1-2 
h (place a fluorescent sticker next to the membrane to facilitate subsequent 
alignment of the film and membrane).  
[Critical Step] The exposure time to obtain sufficient signal on the films varies 
depending on the radioactivity of the samples. From our experience of iCLIP, the 
required exposure time varies from 15 min to overnight.  
[Critical Step] The visualization of SDS-PAGE separated protein-RNA 
complexes is one of the crucial quality control steps. It can be used to assess the 
RNase and purification conditions for both the preliminary and the sample 
preparation experiments (Fig. 5). The length of crosslinked RNA can be 
estimated by the position of the signal on the autoradiograph compared to the 
expected position of the non-crosslinked target protein, which can be determined 
by western blotting. Roughly, a 2 kDa shift indicates that the target protein is 
crosslinked to 7 nts of RNA35. On the other hand, the absence of RNA that is not 
crosslinked to the target RBP can be confirmed by: the absence of the additional 
band for the lane where the sample is loaded; and the absence of signal for the 
lanes where the control samples are loaded (omitting UV crosslinking or 
omitting the induction of the target protein).  
[Pause point] The samples on the membranes can be stored at -80 ˚C for a week. 
? Trouble shooting  
 
74. For each sample, cut the region of membrane containing the protein-RNA 
complexes using the autoradiograph as a guide. The region to be cut is indicated 
in Fig. 5 by the black dotted lines. 
[Critical Step] The diffuse signal above the expected molecular weight of the 
RBP should be excised from the membrane. The length of RNA can be estimated 
by the location of the signal related to the molecular weight of the RBP as 
described at Step 73. Here we purify a broad size range of crosslinked RNA. The 
precise size selection is performed at Step 93.  
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75. Cut the excised membranes into small pieces, and place them into a 1.5 ml 
microfuge tube.  
 
76. Add 200 µl PK buffer with 10 µl proteinase K to the membrane pieces, and 
incubate them at 37°C for 20 min at 1,100 rpm shaking in a Thermomixer. 
 
77. Add 200 µl of PK buffer with 7 M urea to each sample, and incubate for 20 min 
at 37°C and 1,100 rpm in a Thermomixer. 
 
78. Perform acid-PCI extraction and ethanol precipitation to purify the extracted 
RNA as described in Step 4-11. 
[Critical step] Most of the RNA should be extracted from the membrane to the 
solution after proteinase K treatment. Check the extraction efficiency by 
monitoring radioactivity of the materials using a scintillation counter.  
? Troubleshooting 
 
79. Resuspend the RNA pellet in 6.25 µl of nuclease-free water. 
[Pause Point] The purified RNA can be stored for at least a month at -80 ˚C. 
 
[Reverse transcription and cDNA purification; Timing 4 h (plus overnight)] 
80. For each sample, add 1 µL of reverse transcription primer (0.5 µM) and 1 µL of 
dNTPs (10 mM). 
[Critical step] In order to allow multiplexing of samples, use reverse 
transcription primers with different experimental barcodes for different samples 
(see “reverse transcription and multiplexing libraries” section of Experimental 
design).  
 
81. Incubate the samples for 5 min at 70 ˚C in a thermal cycler to denature RNA, and 
hold at 25 ˚C until ready to proceed to the next step . 
 
82. Add 11.75 µl of RT reaction mix as tabulated below to each sample. 
 
Component Amount (µl) 
Final concentration 
(in 20 µL) 
   
37 of 56 
First-strand buffer (5×) 4 1× 
DTT (100 mM) 1 5 mM 
Nuclease-free water 5.75 
 Superscript III RT (200 U µl-1) 0.5 5 U µl-1 
RNasin Plus RNase inhibitor (40 U μl-1) 0.5 1 U µl-1 
Total 11.75   
 
 
83. Perform the reverse transcription reaction in a thermal cycler by incubating the 
samples at 25 ˚C for 5 min, 42 ˚C for 20 min, 50 ˚C for 40 min, 80 ˚C for 5 min, 
and holding at 4 ˚C. 
  
84. Add 2.2 µl of 1 M NaOH to each sample, and incubate at 98 ˚C for 20 min to 
hydrolyse the template RNA.  
 
85. Add 25 µl of 1M HEPES-NaOH to each sample to neutralize the buffer.  
 
86. Add 352.8 µl of TE buffer, 1 µl of linear acrylamide, and 40 µl of sodium acetate 
(3M, pH 5.5), to each sample, and mix. Perform ethanol precipitation as 
described in Step 7-11. 
 
87. Resuspend the cDNA pellet in 6 µl of nuclease-free water. 
[Pause point] The purified cDNA can be stored for at least a month at -20˚C. 
 
88. Add 6 µl of TBE-urea loading buffer (2×) to the cDNA. As a size marker, mix 
100 ng of Low Molecular Weight DNA Ladder in 12 µl of TBE-urea loading 
buffer (1×). 
 
89. Incubate the samples for 5 min at 80°C to denature DNA, and place on ice. 
 
90. Load the samples on a 6% Novex TBE-Urea gel (10 well) and the marker sample 
on the last lane, and perform electrophoresis for 40 min at 180 V using a XCell 
SureLock Mini-Cell with 900 ml of TBE buffer (1×) by following the 
manufacturer’s instructions. 
[Critical step] In order to facilitate gel excision, load samples in alternate wells.. 
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91. Take out the gel from the cassette. Cut off the lane of the gel containing the size 
marker, and stain it by incubating for 10 min shaking in 10 ml TBE buffer with 2 
µl SYBR green II. Wash once with TBE buffer.  
 
92. Visualize the size marker using a UV transilluminator, and print the image.  
 
93. For each sample, excise a region of the gel corresponding to 100–300 nt single-
stranded DNA using the printed image of the size marker from Step 92, and 
place the gel piece with 400 µl of TE buffer into a new 1.5 ml microfuge tube. 
[Critical step] The adaptor sequence accounts for 71 nt of the cDNA. If each arm 
of hybrid reads is longer than 15 nt, the resulting cDNA should be longer than 
100 nt. This is why only regions above 100 nt should be excised. Further details 
of the gel purification procedure have been described previously as part of the 
iCLIP procedure48. 
 
94. Purify and pellet the cDNA from the gel piece as described in step 18-21. 
[Critical step] The cDNA sample should not be radioactive from this step on, 
since the radiolabelled RNA is hydrolysed and removed by the gel 
electrophoresis. Confirm the absence of radioactive signal from the samples 
using a scintillation counter. 
[Pause point] The purified cDNA can be stored for at least a month at -20 ˚C. 
? Troubleshooting 
 
[Circulization and linearization of cDNA; Timing 3 h (plus overnight)] 
95. For each sample, resuspend the cDNA in 8 µl of circularization reaction mix as 
tabulated below, and incubate for 1 h at 60°C in a thermal cycler. 
 
Component Amount (µl) Final concentration 
MnCl2 (50 mM) 0.4 2.5 mM 
CircLigase II reaction buffer (10×) 0.8 1× 
Nuclease-free water 6.5 
 CircLigase II ssDNA ligase (100 U µl-1) 0.3 3.75 U µl-1 
Total 8   
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96. Add 30 µl of oligo annealing reaction mix as tabulated below to each sample. 
 
Component Amount (µl) Final concentration 
FastDigest buffer (10×) 3 1× 
Cut oligo (10 µM) 1 0.3 µM 
Nuclease-free water 26   
Total 30   
 
97. Anneal the cut oligo to the cDNA in a thermal cycler using the following 
programme: 
 
Cycle number Condition 
1 95°C, 2 min 
2-72 
Successive cycles of 20 s, starting from 95°C and decreasing 
the temperature by 1°C each cycle down to 25°C 
73 25˚C, hold 
 
 
98. Add 2 µl of FastDigest BamHI to each sample, and incubate at 37°C for 30 min, 
and then 80 ˚C for 10 min in a thermal cycler.  
 
99. Add 360 µl of TE, 1 µl of linear acrylamide, and 40 µl of sodium acetate (3M, 
pH 5.5) to each sample, and mix. Perform ethanol precipitation as described in 
Step 7-11.  
 
100. Resuspend the cDNA pellet in 11 µl of nuclease-free water. 
[Pause point] The cDNA sample can be stored for at least a month at -20 ˚C. 
 
[PCR amplification of cDNA library: cycle number optimization; Timing 2 h] 
 
101. For each sample, split 1.5 µl of the sample from Step 100 to three new 1.5 ml 
microfuge tubes (0.5 µl each). The remaining 9.5 µl of the sample is used at Step 
108 to produce a library for sequencing.  
[Critical step] The number of PCR cycles required to achieve optimal 
amplification of the cDNA library varies depending on the samples and 
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experimental conditions. Therefore, we always perform this pilot experiment to 
determine the appropriate cycle number. 
 
 
102. Add 9.5 µl of PCR reaction mix as tabulated below to each sample. 
 
Component Amount (µl) 
Final concentration 
(in 10 µL) 
P5Solexa/P3Solexa primer mix (10 µM each) 0.25 0.25 µM 
AccuPrime SuperMix I 5 
 Nuclease-free water 4.25   
Total 9.5   
 
 
103. Perform the PCR amplification in a thermal cycler using the following program: 
 
Cycle number Denature Anneal Extend Final 
1 94˚C, 2 min 
   2-26 (or 2-31) 94˚C, 15 s 65˚C, 30 s 68˚C, 30 s 
 27 (or 32)       68˚C, 3 min; 25˚C, hold 
 
[Critical Step] We test 25 and 30 cycles of PCR amplification to identify the optimal 
cycle number. 
[Critical Step] All the post-PCR experiments should be performed in a dedicated area. 
Since most high-throughput DNA sequencing based methods share the adaptor 
sequences, it is imperative to avoid cross-contamination of post-PCR products 
between samples. 
 
104. For each sample, mix 8 µl of PCR product with 2 µl of sample loading dye (5×) 
in a 1.5 ml microfuge tube. As a size marker, mix 100 ng of Low Molecular 
Weight DNA Ladder in 10 µl of sample loading dye (1×). 
 
105. Load the samples on a 6% Novex TBE gel and the marker sample on the last 
lane, and perform electrophoresis for 25 min at 180 V using a XCell SureLock 
Mini-Cell with 900 ml of TBE buffer (1×) by following the manufacturer’s 
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instructions. 
 
106. Take out the gel from the cassette, and stain it by incubating for 10 min shaking 
in 10 ml TBE buffer with 1 µl SYBR safe. Wash once with TBE buffer. 
 
107. Visualize DNA in the gel using a UV transilluminator, and determine the optimal 
PCR cycle number for library preparation. The ideal PCR cycle number 
produces a band within the expected DNA size range and minimal primer dimers 
(Fig. 7). 
[Critical Step] It is also important to confirm that the library is at a linear 
amplification stage during PCR and at a sufficient concentration for sequencing28. 
We generally aim for the amplified DNA to have approximately similar signal 
intensity as the size marker on the gel. The PCR gel can also be used to confirm 
the absence of background signal from non-crosslinked RNA. The PCR band 
should only exist for the hiCLIP sample and not control samples. 
? Troubleshooting 
 
[PCR amplification of cDNA library; Timing 2 h] 
108. For each sample from Step 101, transfer 5 µl of the sample to a new 1.5 ml 
microfuge tube. 
 
109. Add 95 µl of PCR reaction mix as tabulated below to each sample. If it exceeds 
the maximum volume recommended for the thermal cycler, split it across 
multiple tubes so that the volume in a single tube is appropriate.  
 
Component Amount (µl) 
Final concentration 
(in 100 µL) 
P5Solexa/P3Solexa primer mix (10 µM each) 2.5 0.25 µM 
AccuPrime SuperMix I 50 
 Nuclease-free water 42.5   
Total 95   
 
 
110. Perform PCR amplification as described in Step 103 with the cycle number 
determined in Step 107. 
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111. To confirm the appropriate amplification of the library, transfer 8 µl of the post-
PCR sample to a new 1.5 µl microfuge tube. Mix it with 2 µl of sample loading 
dye (5×). As a size marker, mix 100 ng of low molecular weight DNA ladder in 
10 µl of sample loading dye (1×). 
 
112. Load the samples on a 6% Novex TBE gel and the marker sample on the last 
lane, and perform electrophoresis for 25 min at 180 V using a XCell SureLock 
Mini-Cell with 900 ml of TBE buffer (1×) by following the manufacturer’s 
instructions. Visualize the samples as described in Step 105-107. Confirm that 
the band is within the expected DNA size range, and the signal from primer 
dimers is minimal. (See Step 107 and Fig. 7)  
? Troubleshooting 
 
113. Purify the remaining 92 µl of post-PCR sample from Step 110 using AMpure XP 
by following the manufacturer’s instructions. After the purification, resuspend 
the sample in 20 µl of nuclease-free water. 
[Pause point] The post-PCR library can be stored for at least 3 months at -20 ˚C. 
 
[Library quantification and high-throughput DNA sequencing; Timing 2 h (plus 24 
h)] 
 
114. For each sample, prepare 2 µl of serial dilutions (1/100, 1/1,000, 1/10,000, and 
1/100,000) in a 96-well plate for qPCR. Also prepare 2 µl of reference libraries 
with known concentration at 100 pM, 10 pM, 1 pM and 0.1 pM.  
[Critical Step] The reference libraries must contain adaptor sequences that can be 
amplified by qPCR primer 1 and 2 as well as the sequence that can anneal to 
DLP oligo.   
 
115. Add 18 µL of qPCR reaction mix below to each qPCR sample. Note that the 
DLP oligo anneals to the adaptor region of the hiCLIP library, and thus can 
quantify hiCLIP library for any RBP generated using the adaptors described here. 
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Component Amount (µl) 
Final concentration 
(in 20 µL) 
DLP oligo (10 µM) 0.5 0.25 µM 
qPCR primer 1 (10 µM) 0.6 0.3 µM 
qPCR primer 2 (10 µM) 0.6 0.3 µM 
Platinum Quantitative PCR SuperMix-UDG 
w/ROX 10 
 Nuclease-free water 6.3   
Total 18   
 
116. Seal the plate with MicroAmp optical adhesive film. 
 
117. Perform qPCR in a qPCR machine following the manufacturer’s instructions 
with the following method (Detector: FAM-TAMRA; Passive reference: ROX) 
and the following program: 
  
Cycle number UDG incubation*  Denature Anneal Extend 
1 54˚C, 2 min 
   2 
 
94˚C, 10 min 
  3-42   94˚C, 15 s 62˚C, 1 min 72˚C, 30s 
* Uracil-DNA glycosylase (UDG) incubation step is included to eliminate contaminating 
DNA from the previous qPCR experiments.  
  
118. Plot the concentrations of reference libraries versus the Ct values on a log scale, 
and fit a straight line. The formula of the line can be used to calculate the 
concentration from the Ct value. Average the concentrations of the samples 
estimated from the serial dilution, and use the average concentration as the 
sample concentration.  
 
119. We multiplex all the libraries where the signal can be observed by the gel at Step 
107 (Fig. 7; hiCLIP replicates together with the control sample that omits the 
second round of ligation). Sequence the library using a MiSeq Gene & Small 
Genome Sequencer and MiSeq Reagent Kit following the manufacturer’s 
instruction. We sequenced 196 bases for the hiCLIP library of STAU18. 
? Troubleshooting 
 
[Bioinformatic analysis: Setting the environment; TIMING seconds] 
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[Critical] All of the commands for the bioinformatic analysis (steps 120 – 139) are 
intended to be run in R. Each command is prefixed here with either the terminal 
command prompt “$” or the R command prompt “>” which does not need to be 
entered. Each R function is associated with a help file that can be consulted if needed. 
 
120. Open R. If using RConsole or RStudio for Mac OS X, open from the terminal 
rather than clicking on the icon to allow R to access the system’s PATH 
environment variable. 
(A) RConsole 
$ open -a R 
 
(B) RStudio 
$ open -a RStudio 
 
121. Load the “hiclipr” library. Create the directory structure within the specified 
working directory and set the working directory (in this example “~/hiCLIP”). 
> library(hiclipr) 
> CreateDirectories(folder = "~/hiCLIP") 
 
[Bioinformatic analysis: Pre-processing the reads; Timing: 30 min] 
 
122. Download the raw sequencing reads (FASTQ files) from the sequencer to the 
“data” folder. This example uses “LUs27_196.fq.gz” from the original hiCLIP 
paper8, which can be downloaded from the European Nucleotide Archive 
(experiment accession: ERR605257). 
> download.file(url = 
"ftp://ftp.sra.ebi.ac.uk/vol1/ERA358/ERA358132/fastq/LUs27_196.fq.gz", 
destfile = "data/LUs27_196.fq.gz") 
 
123. Extract the UMI (positions 1-2 and 7-9 at the 5' end of the read) and save as tab-
separated values for collapsing PCR duplicates downstream. The output FASTQ 
file is renamed with the suffix “_reordered”. Both output files are saved in the 
“results/processed_data” folder. 
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> ExtractRandomBarcodes(fq.file = "LUs27_196.fq.gz", barcode.filename = 
"LUs27_196_barcode.tsv") 
 
124. Use the experimental barcode (positions 3-6 at the 5' end of the read) to 
demultiplex the experiments, specifying the experiment names. The 
demultiplexed reads are renamed according to the experiment names and saved 
in the “results/processed_data” folder. In this example, “LigPlusLow” 
corresponds to low RNase and “LigPlusHigh” to high RNase conditions, while 
LigMinus corresponds to the control sample (where the second round of ligation 
is omitted). 
> DemultiplexReads(fq.file = "LUs27_196_reordered.fq.gz", LigPlusLow = 
"AATA", LigPlusHigh = "GGTT", LigMinus = "GGCG") 
 
125. Identify and select the hybrid reads specifying the adapters. The output FASTQ 
file is renamed with the suffix “_hybrid” and saved in the 
“results/processed_data” folder. 
> SelectHybrid(fq.file = "LigPlusLow.fq.gz", adapterA = 
"AGATCGGAAGAGCGGTTCAG", adapterB = "CTGTAGGCACCATACAATG") 
> SelectHybrid(fq.file = "LigPlusHigh.fq.gz", adapterA = 
"AGATCGGAAGAGCGGTTCAG", adapterB = "CTGTAGGCACCATACAATG") 
 
[Bioinformatic analysis: Align the hybrid reads; Timing: variable, a few hours] 
 
126. Create the Bowtie index files in the “ref/bowtie” folder for the four-stage 
alignment strategy. This only needs to be performed first time the pipeline is run. 
The function will download the relevant FASTA files and create four indices: a 
ribosomal and transfer RNA index (prefix: rRNA_tRNA); a mitochondrial and 
pre-rRNA index (prefix: mtDNA_prerRNA); a transcriptome index using the 
longest RNA transcript for each gene (prefix: longestRNA); a genome index 
(prefix: GRCh37) 
> CreateBowtieIndices() 
 
NOTE: Ensembl GRCh37 release 75 has been used. 
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127. Apply the four-phase alignment strategy, specifying the aligned BAM filename 
and number of processors to be used. The BAM alignment file will be output to 
the “results/mapped” folder. 
> AlignReadsBowtie(fq.file = "LigPlusLow_hybrid.fq", bam.file = 
"LigPlusLow.bam", processors = 2) 
> AlignReadsBowtie(fq.file = "LigPlusHigh_hybrid.fq", bam.file = 
"LigPlusHigh.bam", processors = 2) 
 
[Caution] The number of processors specified should be less than half the total 
available as AlignReadsBowtie runs two processes in parallel. 
[Critical step]  For alignment phase 1 (to rRNA and tRNA) and 2 (to mtDNA 
and pre-rRNA), reads are allowed to align to multiple locations (with primary 
alignments carried forward) due to their high sequence redundancy. This also 
prevents them from impacting upon alignment phase 3 (to the transcriptome), 
where much of the analysis is focused and only uniquely aligned reads are 
considered to ensure validity of the results. 
 
[Bioinformatic analysis: Post-processing; Timing: 30 min] 
 
128. Load the BAM files in turn and ensure only valid hybrid reads are kept (i. e. both 
hybrid arms have been aligned) 
> LigPlusLow.hybrids <- LoadBAM(bam.file = "LigPlusLow.bam") 
> LigPlusHigh.hybrids <- LoadBAM(bam.file = "LigPlusHigh.bam") 
 
129. Collapse PCR duplicates (defined as hybrid reads that have the same UMI and 
the same seqname, start and strand SAM fields). The previously created barcode 
file is passed to the function. The frequency table of PCR duplicates is output to 
the console. 
> LigPlusLow.collapsed <- EvaluateBarcodes(bam.dt = LigPlusLow.hybrids, 
barcodeindex = "LUs27_196_barcode.tsv") 
> LigPlusHigh.collapsed <- EvaluateBarcodes(bam.dt = 
LigPlusHigh.hybrids, barcodeindex = "LUs27_196_barcode.tsv") 
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130. Annotate the hybrids with the transcript biotype and transcript region (e.g. 5’ 
UTR, CDS, 3’ UTR). Then combine the two for downstream analysis (as in the 
original paper8). 
> LigPlusLow.annotated <- AnnotateHybrid(LigPlusLow.collapsed) 
> LigPlusHigh.annotated <- AnnotateHybrid(LigPlusHigh.collapsed) 
> annotated.hybrids <- rbind(LigPlusLow.annotated, 
LigPlusHigh.annotated) 
 
131. Select hybrids that are mapped to transcripts (i. e. not ribosomal or transfer 
RNA). There is the option to select mature or immature transcripts; if immature 
transcripts are selected, introns are included (in genomic coordinates). There is 
also the option to select intragenic or intergenic hybrids. Intragenic hybrids are 
used for downstream analysis. 
> intragenic.hybrids <- SelectGenicHybrid(annotated.hybrids, type = 
"intra", class = "mature") 
 
132.  FOR INTRAGENIC HYBRIDS ONLY: Create a set of non-redundant hybrids 
from the intragenic hybrids. When more than two hybrids cover the same area 
(with a specified minimum width and coverage), they are collapsed with the 
coverage providing a level of confidence in these hybrids reads. They are merged 
with the remaining hybrids to create the non-redundant set of hybrids. 
> islands <- FindIslands(intragenic.hybrids, minimum.coverage = 2, 
minimum.width = 8) 
> nonislands <- FindNonIslandHybrids(intragenic.hybrids, islands) 
> nonredundant.hybrids <- CreateNonRedundantHybrids(islands, 
nonislands) 
 
133. FOR INTRAGENIC HYBRIDS ONLY:  Identify the duplexes from the non-
redundant hybrids. The duplex sequences are obtained and RNAhybrid46 used to 
identify the duplexes. 
> hybrid.sequences <- GetSequence(nonredundant.hybrids) 
> RunRNAHybrid(hybrid.sequences, "rnahybrid.out") 
> nonredundant.duplexes <- FindDuplex(hybrid.sequences, 
"rnahybrid.out") 
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[Caution] The RNAHybrid output file (in this example “rnahybrid.out”) is 
written to the “results/RNAhybrid” directory.  RunRNAhybrid will not work if 
the file already exists. 
 
[Bioinformatic analysis: Plots; Timing: variable; a few minutes] 
 
CRITICAL. All the plots are saved in the “plots” folder. 
 
134. Plot the regions to which the hybrid arms map.  
> hybrids <- rbind(LigPlusLow.hybrids, LigPlusHigh.hybrids) 
> annotated <- AnnotateHybrid(hybrids) 
> PlotHybridRegion(annotated, filename = "hybrid_region.png") 
 
[Caution] Our strategy for processing the unique molecular identifier is not suitable 
for evaluating the cDNA of origin of reads aligned to multiple locations (i.e. phase 1), 
because it considers the alignment location in conjunction with the unique molecular 
identifier. This could lead to underestimating the number of PCR duplicates for this 
phase. However, for this plot, we assume the rate of PCR duplication is reasonably 
uniform across regions and so the relative proportion of regions to which the hybrid 
arms map are unlikely to be affected. 
 
135. Plot the ratio of intragenic to intergenic reads. 
> genic.hybrids <- SelectGenicHybrid(annotated.hybrids, type = "all", 
class = "mature") 
> PlotIntraInterRatio(genic.hybrids, filename = 
"intra_inter_ratio.png") 
 
136. Compare intragenic and intergenic regions 
> PlotGenicRegion(genic.hybrids, type = "bar", filename = 
"genic_region.png") 
 
137. Plot the mate for hybrid arms mapped to a particular region (in this example, 3’ 
UTR). 
> PlotRegionMate(intragenic.hybrids, region = "UTR3", filename = 
"region_mate.png") 
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138. Plot the loop length distribution for non-redundant duplexes. These can be 
weighting according to coverage of the islands/duplexes. 
> PlotLoopLength(nonredundant.duplexes, weighting = TRUE, ratio = 
FALSE, filename = "loop_length.png") 
 
[Bioinformatic analysis: Export intragenic duplexes for visualization; Timing: 30 
mins] 
 
139. Convert the non-redundant duplexes from transcriptomic to genomic coordinates 
for visualization in a genome browser. The exported BED file is written to the 
“results” folder. 
> ExportBED(nonredundant.duplexes, filename = 
"nonredundant_duplexes.bed") 
 
TROUBLESHOOTING 
Troubleshooting advice can be found in Table 2 
 
TIMING 
● Step 1-22, Preparation of adaptors: 2h, overnight RNA precipitation, ~5h the 
following day 
● Step 23-30, Preparation of cells and UV crosslinking: ~2 days (depending of the 
growth of the cell) 
● Step 31-33, Preparation of antibody-coupled beads: 4 h 
● Step 34-39, Cell lysis and partial RNA digestion:  2 h 
● Step 40-48, First round of immunoprecipitation:  3-4 h 
● Step 49-50, 3ʹ  end dephosphorylation:  1 h 
● Step 51-52, First round of ligation (adaptor ligation): 30 min, overnight ligation, 30 
min the following day 
● Step 53-54, 5ʹ  end phosphorylation of RNA and removal of adaptor B’s phosphate 
blocking:  1 h 
● Step 55-56, Second round of ligation (hybrid generation):  30 min, overnight 
ligation, 30 min the following day 
● Step 57-60, Preparation of antibody-attached beads:  2-3 h 
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● Step 61-65, Second round of immunoprecipitation:  3 h 
● Step 66-67, Radiolabelling of RNA:  30 min 
● Step 68-72, SDS-PAGE and nitrocellulose membrane transfer:  3h 
● Step 73-79, RNA isolation:  ~4 h, overnight precipitation, 1h the following day 
● Step 80-94, Reverse transcription and cDNA purification:  3 h 
● Step 95-100, Circulization and linearization of cDNA:  3 h 
● Step 101-107, PCR amplification of cDNA library (the cycle number optimisation):  
2 h 
● Step 108-113, PCR amplification of cDNA library:  2 h 
● Step 114-119, Library quantification and high-throughput DNA sequencing:  2 h, 
~24 h for the sequencing 
● Step 120-139, Bioinformatic analysis:  ~1 day 
 
ANTICIPATED RESULTS 
hiCLIP generates hybrid RNAs from RNA duplexes bound by the RBP of interest;  
the two arms of the duplexes are ligated via a linker. Those hybrid RNAs crosslinked 
to the RBP are purified and converted into a high-throughput DNA sequencing 
compatible library. The high-throughput DNA sequencing data can be used to 
investigate RNA duplexes as described in the overview.  
 
The results of hiCLIP will depend on the RBPs and biological conditions studied. 
Here we summarize the key statistics when we applied hiCLIP to FLAG-tagged 
STAU1 of Flp-In 293 T-REx cells as an example. Using cells growing on ten 15 cm 
dishes, approximately 35,000 hybrid reads were obtained. The proportion of hybrid 
reads among all the reads where the RNA source can be identified was 1 – 2 %. 
 
The output of the bioinformatic analysis of this example dataset is shown in Fig. 3. 
This includes the following analyses: the source of hybrid RNAs, the proportion of 
intragenic and intergenic hybrids and the distance between the RNA duplex arms in 
CDS and 3’ UTRs. In case of STAU1 target RNA duplexes, intra-molecular RNA 
duplexes dominated over inter-molecular RNA duplexes and a longer distance 
between intra-molecular RNA duplex arms in the 3’ UTRs was observed compared to 
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in the CDS. Although we primarily focused on intra-molecular RNA duplexes due to 
their dominance in this dataset, the same approach should be applicable to inter-
molecular RNA duplexes.  A BED file is also created to visualize the RNA duplexes 
in standard genome browsers such as the University of California Santa Cruz (UCSC) 
genome browser49 and the Integrative Genomics Viewer (IGV)50 (Fig. 4). 
 
The “hiclipr” package was developed to allow researchers to analyze their own 
hiCLIP data easily. To this end, the original pipeline has been updated and refined 
and there are now fewer dependencies. Thus, the results obtained by the “hiclipr” 
package are very similar to the original study, but there are some differences. These 
are accounted for largely by: (i) the use of a more recent Ensembl release and (ii) the 
updated method of hybrid read selection building on the original as described in 
Experimental design. 
 
hiCLIP offers a universal approach to study RNA duplexes recognized by a specific 
RBP. The experimental and computational procedure described here can be used to  
study any RBPs bound to RNA duplexes and biological conditions, and thus advance 
understanding of the role of RNA structures and RBPs in post-transcriptional 
regulation.  
 
Figure legends 
 
Figure 1 | Overview of high-throughput methods to study in vivo RNA structures 
 
Figure 2 | Schematic overview of the hiCLIP procedure 
 
Figure 3 | Anticipated results and comparison with the original pipeline  
The left-hand plots are from the new pipeline while the right-hand plots are from the 
original paper. The top panel (A) shows the summary of regions to which the hybrid 
arms align. The middle panel (B) shows the proportion of intragenic and intergenic 
hybrid reads. The bottom panel (C) shows the density distribution of loop lengths of 
duplexes in the CDS and 3’ UTR regions. The differences in these three plots can be 
accounted for by the use of a newer Ensembl annotation release and an updated 
method of hybrid read selection. The outputs of the original pipeline are reproduced 
from Sugimoto et al. (2015)8. 
  
Figure 4 | Example genome browser view 
The genome browser view for XBP1 is shown using the UCSC genome browser. 
External data tracks can be added as desired by the user; here we have selected 
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conservation and single nucleotide polymorphism tracks. The difference between the 
hybrids and the duplexes contained within them is also shown. 
 
Figure 5 | Quality control of hiCLIP by autoradiograph  
The checkpoints for examining the autoradiographs, and their implications, are shown 
together with representative gel images. The gel images are reproduced from 
Sugimoto et al. (2015)8. 
 
Figure 6 | Adaptor preparation (adenylation and purification)  
RNA adaptor A and RNA adaptor B are adenylated, and analyzed by PAGE. The 
RNA adaptors are visualized by SYBR Green II here, but for the actual purification 
experiments, we used UV-shadowing. The bands corresponding to the adenylated 
adaptors are indicated by red arrows. The bands are excised and the adenylated 
adaptors extracted from the gel. 
 
Figure 7 | PCR cycle number optimization for cDNA library amplification  
The gel images of PCR cycle number optimization experiments are shown. The left 
panel summarizes the checkpoints for preliminary experiments to determine the 
appropriate PCR cycle number together with a representative gel image and its 
implications. Based on the result of the preliminary experiment, a PCR cycle number 
of 24 was chosen. The right panel shows a representative gel image of PCR amplified 
cDNA libraries suitable for high-throughput DNA sequencing. 
 
Table 1 | Oligonucleotides  
5Phos, 3Phos, dd, r, N, 6FAM and TAMRA indicate 5ʹ  phosphorylation, 3ʹ  
phosphorylation, dideoxynucleotide, ribonucleotide, random nucleotide, 5' 6-FAM 
and 3' TAMRA modification respectively. All the oligonucleotides are generic and 
should be applicable for the study of any RBPs. 
 
Table 2 | Troubleshooting 
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Figure 5 | Quality control of hiCLIP by autoradiograph
Figure 6 | Adaptor preparation (adenylation and purification)
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Figure 7 | PCR cycle number optimization for cDNA library amplification
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